DDR2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0FGR8 | Y824 | Sugiyama | ESYT2 FAM62B KIAA1228 | IVVVHACRNLIAFSEDGsDPyVRMYLLPDKRRSGRRKTHVS |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A5YKK6 | Y851 | Sugiyama | CNOT1 CDC39 KIAA1007 NOT1 AD-005 | QVWPEANQHFSKEIDDEANSyFQRIYNHPPHPTMSVDEVLE |
| A6NHL2 | Y319 | Sugiyama | TUBAL3 | TTACFESSNQLVKCDPRLGKyMACCLLyRGDVVPKEVNAAI |
| A6NMY6 | Y30 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | KLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAIKTKG |
| A6NMY6 | Y316 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | SEVDMLKIRSEFKRKYGKsLyyyIQQDTKGDyQKALLyLCG |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00429 | Y101 | Sugiyama | DNM1L DLP1 DRP1 | EENGVEAEEWGKFLHTKNKLyTDFDEIRQEIENETERISGN |
| O00469 | S441 | Sugiyama | PLOD2 | HGKLWSNFWGALSPDGYYARsEDyVDIVQGNRVGVWNVPYM |
| O00469 | Y444 | Sugiyama | PLOD2 | LWSNFWGALSPDGYYARsEDyVDIVQGNRVGVWNVPYMANV |
| O00764 | Y79 | Sugiyama | PDXK C21orf124 C21orf97 PKH PNK PRED79 | SDELQELyEGLRLNNMNKyDyVLTGYTRDKSFLAMVVDIVQ |
| O14672 | Y415 | Sugiyama | ADAM10 KUZ MADM | SGTECTPGESKNLGQKENGNyIMYARATSGDKLNNNKFSLC |
| O14744 | Y337 | Sugiyama | PRMT5 HRMT1L5 IBP72 JBP1 SKB1 | DNLESQTyEVFEKDPIKYsQyQQAIyKCLLDRVPEEEKDTN |
| O14776 | Y1057 | Sugiyama | TCERG1 CA150 TAF2S | IQESDQHLKDVEKILQNDKRyLVLDCVPEERRKLIVAyVDD |
| O14818 | Y176 | Sugiyama | PSMA7 HSPC | WKANAIGRGAKSVREFLEKNyTDEAIETDDLTIKLVIKALL |
| O14828 | Y35 | Sugiyama | SCAMP3 C1orf3 PROPIN1 | sELDNPFQDPAVIQHRPsRQyATLDVyNPFETREPPPAyEP |
| O14910 | S130 | Sugiyama | LIN7A MALS1 VELI1 | ELPKTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLK |
| O14910 | Y133 | Sugiyama | LIN7A MALS1 VELI1 | KTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGD |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14974 | S912 | Sugiyama | PPP1R12A MBS MYPT1 | TssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDSTDF |
| O14974 | Y911 | Sugiyama | PPP1R12A MBS MYPT1 | ETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDSTD |
| O14980 | Y469 | Sugiyama | XPO1 CRM1 | DsINLyKNMRETLVyLTHLDyVDTERIMTEKLHNQVNGTEW |
| O15067 | Y538 | Sugiyama | PFAS KIAA0361 | GAGGNGNVLKELsDPAGAIIytsRFQLGDPTLNALEIWGAE |
| O15212 | Y82 | Sugiyama | PFDN6 HKE2 PFD6 | PVLVKQELGEARAtVGKRLDyItAEIKRYESQLRDLERQsE |
| O15357 | Y576 | Sugiyama | INPPL1 SHIP2 | GFVNCHLTSGNEKTARRNQNyLDILRLLSLGDRQLNAFDIS |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O15460 | Y47 | Sugiyama | P4HA2 UNQ290/PRO330 | IGHMTDLIYAEKELVQSLKEyILVEEAKLSKIKSWANKMEA |
| O15460 | Y87 | Sugiyama | P4HA2 UNQ290/PRO330 | ALTSKSAADAEGyLAHPVNAyKLVKRLNTDWPALEDLVLQD |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43390 | Y376 | Sugiyama | HNRNPR HNRPR | ILEKSFSEFGKLERVKKLKDyAFVHFEDRGAAVKAMDEMNG |
| O43390 | Y434 | Sugiyama | HNRNPR HNRPR | KKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGG |
| O43615 | Y201 | Sugiyama | TIMM44 MIMT44 TIM44 | QGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEFAGDKFKEE |
| O43684 | Y194 | Sugiyama | BUB3 | RESSLKYQTRCIRAFPNKQGyVLSSIEGRVAVEyLDPsPEV |
| O43707 | Y234 | Sugiyama | ACTN4 | KLRKDDPVTNLNNAFEVAEKyLDIPKMLDAEDIVNtARPDE |
| O43707 | Y441 | Sugiyama | ACTN4 | KAsIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEs |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43765 | T194 | Sugiyama | SGTA SGT SGT1 | KHVEAVAYYKKALELDPDNEtyKsNLKIAELKLREAPSPTG |
| O43776 | Y45 | Sugiyama | NARS1 NARS NRS | PFKTGLKALMTVGKEPFPtIyVDsQKENERWNVISKsQLKN |
| O43813 | Y10 | Sugiyama | LANCL1 GPR69A | ___________MAQRAFPNPyADyNKsLAEGyFDAAGRLTP |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O43865 | Y291 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | LCVPAMNVNDSVTKQKFDNLyCCRESILDGLKRTTDVMFGG |
| O60427 | Y19 | Sugiyama | FADS1 FADSD5 | __MAPDPVAAETAAQGPTPRyFTWDEVAQRSGCEERWLVID |
| O60488 | Y582 | Sugiyama | ACSL4 ACS4 FACL4 LACS4 | DGCLQIIDRKKDLVKLQAGEyVsLGKVEAALKNCPLIDNIC |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60506 | Y373 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ILEKAFsQFGKLERVKKLKDyAFIHFDERDGAVKAMEEMNG |
| O60506 | Y47 | Sugiyama | SYNCRIP HNRPQ NSAP1 | FQTLLDAGLPQKVAEKLDEIyVAGLVAHsDLDERAIEALKE |
| O60568 | Y444 | Sugiyama | PLOD3 | LWSNFWGALSPDEYYARSEDyVELVQRKRVGVWNVPYISQA |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60716 | S225 | Sugiyama | CTNND1 KIAA0384 | NFHyPPDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsM |
| O60716 | Y228 | Sugiyama | CTNND1 KIAA0384 | yPPDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGy |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| O60814 | Y38 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O60814 | Y43 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| O60832 | Y153 | Sugiyama | DKC1 NOLA4 | IVCIERATRLVKSQQSAGKEyVGIVRLHNAIEGGTQLsRAL |
| O75116 | Y1197 | Sugiyama | ROCK2 KIAA0619 | VSSKKILFYDSEQDKEQSNPyMVLDIDKLFHVRPVtQtDVY |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75369 | T1575 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | QITDQEGKPKRAIVHDNKDGtyAVtyIPDKtGRYMIGVTYG |
| O75369 | Y315 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | DPEGNKEEAQVTPDSDKNKTySVEyLPKVTGLHKVTVLFAG |
| O75533 | Y152 | Sugiyama | SF3B1 SAP155 | RLDPFADGGKtPDPKMNARTyMDVMREQHLTKEEREIRQQL |
| O75718 | Y206 | Sugiyama | CRTAP CASP | AYYKSLPGAEDyIKDLETKSyESLFIRAVRAYNGENWRTSI |
| O75794 | Y301 | Sugiyama | CDC123 C10orf7 D123 | EQDSPAFRCTNSEVtVQPsPyLsyRLPKDFVDLsTGEDAHK |
| O75817 | Y38 | Sugiyama | POP7 RPP20 | VEytLRKRLPSRLPRRPNDIyVNMKTDFKAQLARCQKLLDG |
| O75822 | Y243 | Sugiyama | EIF3J EIF3S1 PRO0391 | KKGVVPGGGLKATMKDDLADyGGyDGGyVQDyEDFM_____ |
| O75822 | Y254 | Sugiyama | EIF3J EIF3S1 PRO0391 | ATMKDDLADyGGyDGGyVQDyEDFM________________ |
| O75874 | Y391 | Sugiyama | IDH1 PICD | FMTKDLAACIKGLPNVQRsDyLNTFEFMDKLGENLKIKLAQ |
| O94829 | Y34 | Sugiyama | IPO13 KIAA0724 RANBP13 | GAAPALDFTVENVEKALHQLyYDPNIENKNLAQKWLMQAQV |
| O95208 | S18 | Sugiyama | EPN2 KIAA1065 | ___MTTSSIRRQMKNIVNNysEAEIKVREATSNDPWGPSSS |
| O95208 | Y17 | Sugiyama | EPN2 KIAA1065 | ____MTTSSIRRQMKNIVNNysEAEIKVREATSNDPWGPSS |
| O95347 | Y938 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | SKHKREAEDGAAKVSKMLKDyDWINAERHLFGQPNSAYDFK |
| O95433 | Y323 | Sugiyama | AHSA1 C14orf3 HSPC322 | EGRGIPAPEEERTRQGWQRyyFEGIKQTFGYGARLF_____ |
| O95573 | Y591 | Sugiyama | ACSL3 ACS3 FACL3 LACS3 | DGCLKIIDRKKDLVKLQAGEyVsLGKVEAALKNLPLVDNIC |
| O95757 | Y30 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | FLNCYIAVARsGGIETIANEySDRCtPACIsLGSRTRAIGN |
| O95881 | Y137 | Sugiyama | TXNDC12 TLP19 UNQ713/PRO1376 | FLDPSGKVHPEIINENGNPsyKyFyVsAEQVVQGMKEAQER |
| O96019 | Y69 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPLK |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00390 | Y371 | Sugiyama | GSR GLUR GRD1 | TDDKGHIIVDEFQNtNVKGIyAVGDVCGKALLtPVAIAAGR |
| P00505 | Y179 | Sugiyama | GOT2 KYAT4 | KPTWGNHtPIFRDAGMQLQGyRYYDPKtCGFDFtGAVEDIS |
| P00505 | Y96 | Sugiyama | GOT2 KYAT4 | VLPSVRKAEAQIAAKNLDKEyLPIGGLAEFCKASAELALGE |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00558 | Y196 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MVGVNLPQKAGGFLMKKELNyFAKALEsPERPFLAILGGAK |
| P02786 | Y152 | Sugiyama | TFRC | sEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVENQ |
| P02786 | Y168 | Sugiyama | TFRC | NENsyVPREAGsQKDENLALyVENQFREFKLSKVWRDQHFV |
| P02786 | Y402 | Sugiyama | TFRC | KEIKILNIFGVIKGFVEPDHyVVVGAQRDAWGPGAAKSGVG |
| P04040 | Y308 | Sugiyama | CAT | QAETFPFNPFDLTKVWPHKDyPLIPVGKLVLNRNPVNYFAE |
| P04040 | Y447 | Sugiyama | CAT | GEVRRFNtANDDNVtQVRAFyVNVLNEEQRKRLCENIAGHL |
| P04075 | Y59 | Sugiyama | ALDOA ALDA | sIAKRLQsIGtENtEENRRFyRQLLLtADDRVNPCIGGVIL |
| P04181 | Y55 | Sugiyama | OAT | QGPPtSDDIFEREyKyGAHNyHPLPVALERGKGIyLWDVEG |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04406 | Y94 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | ItIFQERDPsKIKWGDAGAEyVVEstGVFttMEKAGAHLQG |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05023 | Y542 | Sugiyama | ATP1A1 | LLHGKEQPLDEELKDAFQNAyLELGGLGERVLGFCHLFLPD |
| P05067 | Y308 | Sugiyama | APP A4 AD1 | REVCSEQAETGPCRAMISRWyFDVTEGKCAPFFyGGCGGNR |
| P05187 | Y191 | Sugiyama | ALPP PLAP | TRVQHAsPAGtyAHtVNRNWysDADVPASARQEGCQDIATQ |
| P05388 | Y13 | Sugiyama | RPLP0 | ________MPREDRATWKSNyFLKIIQLLDDyPKCFIVGAD |
| P05787 | Y204 | Sugiyama | KRT8 CYK8 | NKRTEMENEFVLIKKDVDEAyMNKVELESRLEGLTDEINFL |
| P05997 | Y1311 | Sugiyama | COL5A2 | HPARTCDDLKLCHSAKQsGEyWIDPNQGSVEDAIKVYCNME |
| P06730 | Y34 | Sugiyama | EIF4E EIF4EL1 EIF4F | PPttEEEKtEsNQEVANPEHyIKHPLQNRWALWFFKNDKsK |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | Y131 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ILGVsLAVCKAGAVEKGVPLyRHIADLAGNsEVILPVPAFN |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y287 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | PsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKF |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06737 | Y52 | Sugiyama | PYGL | FNRHLHFTLVKDRNVATTRDyYFALAHTVRDHLVGRWIRTQ |
| P06737 | Y732 | Sugiyama | PYGL | FGMRIDDVAALDKKGYEAKEyyEALPELKLVIDQIDNGFFS |
| P06899 | Y38 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSK |
| P06899 | Y41 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P06899 | Y43 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07237 | Y99 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAG |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y199 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RAEDGsVIDyELIDQDARDLyDAGVKRKGTDVPKWIsIMTE |
| P07355 | Y30 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | KLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAIKTKG |
| P07355 | Y316 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | SEVDMLKIRSEFKRKYGKsLyyyIQQDTKGDyQKALLyLCG |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07741 | Y60 | Sugiyama | APRT | RAAIGLLARHLKATHGGRIDyIAGLDsRGFLFGPSLAQELG |
| P07814 | Y1504 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KPLCELQPGAKCVCGKNPAKyytLFGRsy____________ |
| P07814 | Y1505 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLCELQPGAKCVCGKNPAKyytLFGRsy_____________ |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | Y197 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIGyP |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S470 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEs |
| P08238 | Y192 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08621 | Y146 | Sugiyama | SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1 | yGPIKRIHMVYSKRsGKPRGyAFIEyEHERDMHSAYKHADG |
| P08670 | Y117 | Sugiyama | VIM | KNTRTNEKVELQELNDRFANyIDKVRFLEQQNKILLAELEQ |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P08865 | Y156 | Sugiyama | RPSA LAMBR LAMR1 | EAsyVNLPtIALCNTDSPLRyVDIAIPCNNKGAHSVGLMWW |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09234 | Y8 | Sugiyama | SNRPC | _____________MPKFyCDyCDtyLtHDsPsVRKTHCSGR |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P09923 | Y188 | Sugiyama | ALPI | TRVQHAsPAGtyAHtVNRNWysDADMPASARQEGCQDIATQ |
| P0C7P4 | Y100 | Sugiyama | UQCRFS1P1 UQCRFSL1 | NVPASVCYSHTDIKVPDFSEyRRLEVLDSTKSSRESTEARK |
| P0DPH7 | T225 | Sugiyama | TUBA3C TUBA2 | DNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRFD |
| P10398 | Y155 | Sugiyama | ARAF ARAF1 PKS PKS2 | HCSSKVPTVCVDMSTNRQQFyHsVQDLsGGsRQHEAPsNRP |
| P10586 | Y1381 | Sugiyama | PTPRF LAR | PGQQFTWENSNLEVNKPKNRyANVIAYDHSRVILTSIDGVP |
| P10586 | Y224 | Sugiyama | PTPRF LAR | KYECVATNSAGTRYSAPANLyVRVRRVAPRFSIPPSSQEVM |
| P10696 | Y188 | Sugiyama | ALPG ALPPL ALPPL2 | TRVQHASPAGAYAHTVNRNWysDADVPASARQEGCQDIATQ |
| P10809 | Y227 | Sugiyama | HSPD1 HSP60 | LNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLs |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11047 | Y352 | Sugiyama | LAMC1 LAMB2 | tAEsASECLPCDCNGRsQECyFDPELyRSTGHGGHCTNCQD |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11217 | Y52 | Sugiyama | PYGM | FNRHLHFTLVKDRNVAtPRDyYFALAHTVRDHLVGRWIRTQ |
| P11233 | Y153 | Sugiyama | RALA RAL | DKRQVsVEEAKNRAEQWNVNyVETSAKTRANVDKVFFDLMR |
| P11413 | Y107 | Sugiyama | G6PD | FFKATPEEKLKLEDFFARNsyVAGQyDDAAsyQRLNsHMNA |
| P11498 | Y118 | Sugiyama | PC | HIPDIIKVAKENNVDAVHPGyGFLsERADFAQACQDAGVRF |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P11940 | Y291 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | ERQTELKRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLR |
| P11940 | Y297 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLRKEFsPF |
| P11940 | Y54 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | AGPILsIRVCRDMITRRsLGyAyVNFQQPADAERALDtMNF |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12814 | Y215 | Sugiyama | ACTN1 | KLRKDDPLTNLNTAFDVAEKyLDIPKMLDAEDIVGtARPDE |
| P12814 | Y422 | Sugiyama | ACTN1 | KAsIHEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEs |
| P12814 | Y842 | Sugiyama | ACTN1 | DTDTADQVMASFKILAGDKNyITMDELRRELPPDQAEyCIA |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P12956 | Y103 | Sugiyama | XRCC6 G22P1 | LAVVFYGTEKDKNSVNFKNIyVLQELDNPGAKRILELDQFK |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T582 | Sugiyama | EEF2 EF2 | EEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRL |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | T449 | Sugiyama | PDIA4 ERP70 ERP72 | AATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLsE |
| P13667 | Y137 | Sugiyama | PDIA4 ERP70 ERP72 | VAKIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsRtQ |
| P13667 | Y252 | Sugiyama | PDIA4 ERP70 ERP72 | LAKVDAtAETDLAKRFDVsGyPTLKIFRKGRPYDYNGPREK |
| P13667 | Y273 | Sugiyama | PDIA4 ERP70 ERP72 | PTLKIFRKGRPYDYNGPREKyGIVDyMIEQSGPPSKEILTL |
| P13667 | Y448 | Sugiyama | PDIA4 ERP70 ERP72 | RAATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLs |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13798 | Y17 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | ____MERQVLLsEPEEAAALyRGLSRQPALsAACLGPEVtT |
| P13798 | Y43 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | QPALsAACLGPEVtTQyGGQyRTVHTEWtQRDLERMENIRF |
| P13929 | Y131 | Sugiyama | ENO3 | ILGVSLAVCKAGAAEKGVPLyRHIADLAGNPDLILPVPAFN |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P14174 | S91 | Sugiyama | MIF GLIF MMIF | AQNRSYSKLLCGLLAERLRIsPDRVyINyyDMNAANVGWNN |
| P14174 | Y100 | Sugiyama | MIF GLIF MMIF | LCGLLAERLRIsPDRVyINyyDMNAANVGWNNSTFA_____ |
| P14174 | Y96 | Sugiyama | MIF GLIF MMIF | YSKLLCGLLAERLRIsPDRVyINyyDMNAANVGWNNSTFA_ |
| P14174 | Y99 | Sugiyama | MIF GLIF MMIF | LLCGLLAERLRIsPDRVyINyyDMNAANVGWNNSTFA____ |
| P14550 | Y210 | Sugiyama | AKR1A1 ALDR1 ALR | YLAQNELIAHCQARGLEVTAysPLGSSDRAWRDPDEPVLLE |
| P14618 | Y148 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | GtAEVELKKGATLKITLDNAyMEKCDENILWLDYKNICKVV |
| P14618 | Y370 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | NAVLDGADCIMLSGEtAKGDyPLEAVRMQHLIAREAEAAIy |
| P14625 | Y258 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GNTLGRGTTITLVLKEEAsDyLELDTIKNLVKKYSQFINFP |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P14625 | Y677 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | NMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDM |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14854 | Y34 | Sugiyama | COX6B1 COX6B | TAPFDSRFPNQNQTRNCWQNyLDFHRCQKAMTAKGGDIsVC |
| P14868 | Y253 | Sugiyama | DARS1 DARS PIG40 | NVFTVSYFKNNAyLAQsPQLyKQMCICADFEKVFSIGPVFR |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15328 | Y80 | Sugiyama | FOLR1 FOLR | WRKNACCSTNTSQEAHKDVsyLyRFNWNHCGEMAPACKRHF |
| P15880 | T252 | Sugiyama | RPS2 RPS4 | tLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEFtDH |
| P15880 | Y248 | Sugiyama | RPS2 RPS4 | GCtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQE |
| P16278 | Y444 | Sugiyama | GLB1 ELNR1 | QDCSNPAPLssPLNGVHDRAyVAVDGIPQGVLERNNVITLN |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17706 | Y68 | Sugiyama | PTPN2 PTPT | YRDVSPYDHSRVKLQNAENDyINAsLVDIEEAQRSYILTQG |
| P17844 | Y244 | Sugiyama | DDX5 G17P1 HELR HLR1 | tPGRLIDFLECGKTNLRRTTyLVLDEADRMLDMGFEPQIRK |
| P17980 | Y185 | Sugiyama | PSMC3 TBP1 | PtEyDsRVKAMEVDERPtEQysDIGGLDKQIQELVEAIVLP |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P18031 | Y46 | Sugiyama | PTPN1 PTP1B | EASDFPCRVAKLPKNKNRNRyRDVsPFDHSRIKLHQEDNDy |
| P18124 | Y82 | Sugiyama | RPL7 | RQMYRTEIRMARMARKAGNFyVPAEPKLAFVIRIRGINGVS |
| P18206 | Y822 | Sugiyama | VCL | KAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEPDF |
| P18669 | S137 | Sugiyama | PGAM1 PGAMA CDABP0006 | RsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLK |
| P18669 | Y119 | Sugiyama | PGAM1 PGAMA CDABP0006 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19338 | Y351 | Sugiyama | NCL | FAKNDLAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKV |
| P19338 | Y433 | Sugiyama | NCL | FEDAAEIRLVSKDGKSKGIAyIEFKTEADAEKTFEEKQGtE |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P19338 | Y525 | Sugiyama | NCL | VFEKATFIKVPQNQNGKSKGyAFIEFAsFEDAKEALNSCNK |
| P20042 | Y174 | Sugiyama | EIF2S2 EIF2B | DDGIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDM |
| P20073 | Y478 | Sugiyama | ANXA7 ANX7 SNX OK/SW-cl.95 | FAQMYQKTLGTMIAGDTSGDyRRLLLAIVGQ__________ |
| P20618 | S151 | Sugiyama | PSMB1 PSC5 | PYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASA |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P21333 | Y373 | Sugiyama | FLNA FLN FLN1 | THKVTVLFAGQHIAKsPFEVyVDKsQGDASKVTAQGPGLEP |
| P21980 | Y369 | Sugiyama | TGM2 | PGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKyD |
| P22059 | Y767 | Sugiyama | OSBP OSBP1 | RKKREAEAMKATEDGtPYDPyKALWFERKKDPVTKELTHIy |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22314 | Y60 | Sugiyama | UBA1 A1S9T UBE1 | GMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSVLVSGL |
| P22626 | Y336 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___ |
| P23193 | Y126 | Sugiyama | TCEA1 GTF2S TFIIS | EsTSsGNVsNRKDETNARDTyVsSFPRAPstsDsVRLKCRE |
| P23284 | Y119 | Sugiyama | PPIB CYPB | DFMIQGGDFtRGDGtGGKsIyGERFPDENFKLKHyGPGWVs |
| P23396 | Y34 | Sugiyama | RPS3 OK/SW-cl.26 | DGIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATR |
| P23468 | Y1386 | Sugiyama | PTPRD | PGQQFTWEHSNLEVNKPKNRyANVIAYDHSRVLLSAIEGIP |
| P23468 | Y224 | Sugiyama | PTPRD | KYECVATNSAGTRYSAPANLyVRELREVRRVPPRFSIPPTN |
| P23526 | Y165 | Sugiyama | AHCY SAHH | QLLPGIRGIsEEtTTGVHNLyKMMANGILKVPAINVNDsVt |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23527 | Y38 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSK |
| P23527 | Y41 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P23527 | Y43 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y68 | Sugiyama | CFL1 CFL | ILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAt |
| P23528 | Y82 | Sugiyama | CFL1 CFL | QtVDDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFI |
| P23588 | Y593 | Sugiyama | EIF4B | APEPKKPEENPASKFssASKyAALsVDGEDENEGEDyAE__ |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P23921 | Y74 | Sugiyama | RRM1 RR1 | VELDTLAAETAATLTTKHPDyAILAARIAVSNLHKETKKVF |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24752 | Y219 | Sugiyama | ACAT1 ACAT MAT | NTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVt |
| P24752 | Y256 | Sugiyama | ACAT1 ACAT MAT | IPVtVtVKGQPDVVVKEDEEyKRVDFSKVPKLKTVFQKENG |
| P24752 | Y90 | Sugiyama | ACAT1 ACAT MAT | IAIQGAIEKAGIPKEEVKEAyMGNVLQGGEGQAPTRQAVLG |
| P24844 | Y156 | Sugiyama | MYL9 MLC2 MRLC1 MYRL2 | DEEVDEMyREAPIDKKGNFNyVEFTRILKHGAKDKDD____ |
| P25205 | Y19 | Sugiyama | MCM3 | __MAGtVVLDDVELREAQRDyLDFLDDEEDQGIyQsKVREL |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P25205 | Y45 | Sugiyama | MCM3 | DEEDQGIyQsKVRELIsDNQyRLIVNVNDLRRKNEKRANRL |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25786 | Y6 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______________MFRNQyDNDVtVWsPQGRIHQIEYAM |
| P26599 | Y127 | Sugiyama | PTBP1 PTB | ANTMVNYYTSVTPVLRGQPIyIQFsNHKELKtDSSPNQARA |
| P26639 | Y252 | Sugiyama | TARS1 TARS | YNKFKCRILNEKVNtPtttVyRCGPLIDLCRGPHVRHTGKI |
| P26639 | Y53 | Sugiyama | TARS1 TARS | KKNKEGsGDGGRAELNPWPEyIytRLEMYNILKAEHDsILA |
| P26639 | Y575 | Sugiyama | TARS1 TARS | YHQCATIQLDFQLPIRFNLtyVsHDGDDKKRPVIVHRAILG |
| P26640 | Y300 | Sugiyama | VARS1 G7A VARS VARS2 | yDLPtPPGEKKDVSGPMPDsysPRYVEAAWYPWWEQQGFFK |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27448 | Y56 | Sugiyama | MARK3 CTAK1 EMK2 | GARCRNsIAsCADEQPHIGNyRLLKTIGKGNFAKVKLARHI |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P27824 | T66 | Sugiyama | CANX | KPDTTAPPSSPKVTYKAPVPtGEVyFADsFDRGTLSGWILS |
| P27824 | Y70 | Sugiyama | CANX | TAPPSSPKVTYKAPVPtGEVyFADsFDRGTLSGWILSKAKK |
| P28066 | Y185 | Sugiyama | PSMA5 | CDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLIILKQV |
| P28074 | Y236 | Sugiyama | PSMB5 LMPX MB1 X | RRAIyQATYRDAysGGAVNLyHVREDGWIRVSsDNVADLHE |
| P29144 | Y1052 | Sugiyama | TPP2 | WMTKLDSsDIyNELKEtyPNyLPLyVARLHQLDAEKERMKR |
| P29323 | Y596 | Sugiyama | EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5 | EytDKLQHytsGHMTPGMKIyIDPFtyEDPNEAVREFAKEI |
| P29323 | Y602 | Sugiyama | EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5 | QHytsGHMTPGMKIyIDPFtyEDPNEAVREFAKEIDISCVK |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | S308 | Sugiyama | TKT | PPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQALAKL |
| P29558 | Y105 | Sugiyama | RBMS1 C2orf12 MSSP MSSP1 SCR2 | YGKIVSTKAILDKTTNKCKGyGFVDFDsPAAAQKAVSALKA |
| P30040 | Y115 | Sugiyama | ERP29 C12orf8 ERP28 | DyGDKLNMELSEKYKLDKESyPVFyLFRDGDFENPVPyTGA |
| P30043 | S202 | Sugiyama | BLVRB FLR SCAN | GHFMLRCLttDEyDGHstyPsHQyQ________________ |
| P30085 | T30 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | GGPGAGKGTQCARIVEKyGytHLSAGELLRDERKNPDsQyG |
| P30085 | Y27 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | FVLGGPGAGKGTQCARIVEKyGytHLSAGELLRDERKNPDs |
| P30086 | S104 | Sugiyama | PEBP1 PBP PEBP | WHHFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLV |
| P30086 | Y106 | Sugiyama | PEBP1 PBP PEBP | HFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyE |
| P30086 | Y120 | Sugiyama | PEBP1 PBP PEBP | GtVLsDyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsN |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y100 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRt |
| P30101 | Y264 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | CPHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVM |
| P30101 | Y356 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FVMQEEFsRDGKALERFLQDyFDGNLKRyLKsEPIPESNDG |
| P30101 | Y95 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KGIVPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAy |
| P30520 | Y428 | Sugiyama | ADSS2 ADSS | WNTDISNARAFKELPVNAQNyVRFIEDELQIPVKWIGVGKs |
| P31153 | Y235 | Sugiyama | MAT2A AMS2 MATA2 | LDEMRDALKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGP |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31327 | Y1450 | Sugiyama | CPS1 | GsIDLVINLPNNNTKFVHDNyVIRRTAVDSGIPLLTNFQVT |
| P31483 | Y10 | Sugiyama | TIA1 | ___________MEDEMPKTLyVGNLSRDVTEALILQLFSQI |
| P31939 | T143 | Sugiyama | ATIC PURH OK/SW-cl.86 | QIDIGGVTLLRAAAKNHARVtVVCEPEDyVVVSTEMQSSES |
| P31939 | Y293 | Sugiyama | ATIC PURH OK/SW-cl.86 | AAVGIPLsEDEAKVCMVyDLyKTLtPIsAAyARARGADRMs |
| P31939 | Y362 | Sugiyama | ATIC PURH OK/SW-cl.86 | IAPGyEEEALTILSKKKNGNyCVLQMDQsYKPDENEVRTLF |
| P31939 | Y464 | Sugiyama | ATIC PURH OK/SW-cl.86 | IGAGQQsRIHCTRLAGDKANyWWLRHHPQVLSMKFKTGVKR |
| P31943 | Y180 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | AsQEIAEKALKKHKERIGHRyIEIFKSSRAEVRTHYDPPRK |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31943 | Y82 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EsEDEVKLALKKDRETMGHRyVEVFKSNNVEMDWVLKHtGP |
| P31946 | S212 | Sugiyama | YWHAB | SLAKTAFDEAIAELDtLNEEsyKDstLIMQLLRDNLtLWtS |
| P31946 | Y213 | Sugiyama | YWHAB | LAKTAFDEAIAELDtLNEEsyKDstLIMQLLRDNLtLWtSE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y213 | Sugiyama | SFN HME1 | LAKTtFDEAMADLHtLsEDsyKDstLIMQLLRDNLtLWTAD |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P33121 | T695 | Sugiyama | ACSL1 FACL1 FACL2 LACS LACS1 LACS2 | KAKRPELRNYFRSQIDDLyStIKV_________________ |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33778 | Y38 | Sugiyama | H2BC3 H2BFF HIST1H2BB | AITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSK |
| P33778 | Y41 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P33778 | Y43 | Sugiyama | H2BC3 H2BFF HIST1H2BB | QKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y597 | Sugiyama | HSPA4 APG2 HSPH2 | VDLPIENQLLWQIDREMLNLyIENEGKMIMQDKLEKERNDA |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35269 | Y26 | Sugiyama | GTF2F1 RAP74 | PSsQNVTEYVVRVPKNTTKKyNIMAFNAADKVNFAtWNQAR |
| P35573 | Y106 | Sugiyama | AGL GDE | QQSGSFQYYFLQGNEKSGGGyIVVDPILRVGADNHVLPLDC |
| P35580 | Y13 | Sugiyama | MYH10 | ________MAQRTGLEDPERyLFVDRAVIYNPATQADWTAK |
| P35606 | Y824 | Sugiyama | COPB2 | AFVVEEWVKETHADLWPAKQyPLVtPNEERNVMEEGKDFQP |
| P36776 | Y394 | Sugiyama | LONP1 PRSS15 | KLQQRLGREVEEKIKQTHRKyLLQEQLKIIKKELGLEKDDK |
| P36871 | Y157 | Sugiyama | PGM1 | GPAPEAITDKIFQISKTIEEyAVCPDLKVDLGVLGKQQFDL |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40261 | Y11 | Sugiyama | NNMT | __________MESGFTSKDTyLSHFNPRDYLEKYYKFGSRH |
| P40926 | Y80 | Sugiyama | MDH2 | HtPGVAADLsHIEtKAAVKGyLGPEQLPDCLKGCDVVVIPA |
| P40939 | Y637 | Sugiyama | HADHA HADH | ELLTQMVSKGFLGRKSGKGFyIyQEGVKRKDLNSDMDSILA |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P42025 | Y38 | Sugiyama | ACTR1B CTRN2 | SGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALEGDLFI |
| P42345 | Y47 | Sugiyama | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | SGLKSRNEETRAKAAKELQHyVTMELREMSQEESTRFYDQL |
| P43121 | Y222 | Sugiyama | MCAM MUC18 | YTLQSILKAQLVKEDKDAQFyCELNYRLPSGNHMKEsREVT |
| P43490 | Y188 | Sugiyama | NAMPT PBEF PBEF1 | QKKILAKyLLEtsGNLDGLEyKLHDFGyRGVSSQETAGIGA |
| P43490 | Y34 | Sugiyama | NAMPT PBEF PBEF1 | ATDSYKVTHYKQYPPNTSKVysyFECREKKTENSKLRKVKY |
| P43490 | Y36 | Sugiyama | NAMPT PBEF PBEF1 | DSYKVTHYKQYPPNTSKVysyFECREKKTENSKLRKVKYEE |
| P43490 | Y471 | Sugiyama | NAMPT PBEF PBEF1 | EEYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH |
| P45974 | Y849 | Sugiyama | USP5 ISOT | WVIYNDQKVCASEKPPKDLGyIyFyQRVAS___________ |
| P45974 | Y851 | Sugiyama | USP5 ISOT | IYNDQKVCASEKPPKDLGyIyFyQRVAS_____________ |
| P45974 | Y853 | Sugiyama | USP5 ISOT | NDQKVCASEKPPKDLGyIyFyQRVAS_______________ |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46777 | Y207 | Sugiyama | RPL5 MSTP030 | sKEFNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyI |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46976 | Y332 | Sugiyama | GYG1 GYG | AQPFVSSEERKERWEQGQADyMGADSFDNIKRKLDTYLQ__ |
| P47224 | Y114 | Sugiyama | RABIF MSS4 RASGRF3 | CADCEIGPIGWHCLDDKNSFyVALERVSHE___________ |
| P47756 | Y59 | Sugiyama | CAPZB | LLSSVDQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKy |
| P47897 | S750 | Sugiyama | QARS1 QARS | CSVALAKPFDKFQFERLGyFsVDPDsHQGKLVFNRTVTLKE |
| P47897 | Y748 | Sugiyama | QARS1 QARS | VDCSVALAKPFDKFQFERLGyFsVDPDsHQGKLVFNRTVTL |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P47985 | Y91 | Sugiyama | UQCRFS1 | NVPASVCYSHTDIKVPDFSEyRRLEVLDstKSSRESSEARK |
| P48637 | Y395 | Sugiyama | GSS | yGEEMVQALKQLKDSEERAsyILMEKIEPEPFENCLLRPGs |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48643 | Y446 | Sugiyama | CCT5 CCTE KIAA0098 | EISCALAVSQEADKCPTLEQyAMRAFADALEVIPMALSENS |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49321 | Y540 | Sugiyama | NASP | DMLDLAKIIFKRQETKEAQLyAAQAHLKLGEVSVESENYVQ |
| P49327 | Y2034 | Sugiyama | FASN FAS | DYFVVFSSVSCGRGNAGQsNyGFANsAMERICEKRRHEGLP |
| P49327 | Y2462 | Sugiyama | FASN FAS | NVMLLRAKtGGAyGEDLGADyNLsQVCDGKVsVHVIEGDHR |
| P49368 | Y437 | Sugiyama | CCT3 CCTG TRIC5 | AVAHALTEKSKAMtGVEQWPyRAVAQALEVIPRTLIQNCGA |
| P49588 | Y295 | Sugiyama | AARS1 AARS | GARPYTGKVGAEDADGIDMAyRVLADHARTITVALADGGRP |
| P49642 | Y391 | Sugiyama | PRIM1 | EAESDVKHRTRDYKKTSLAPyVKVFEHFLENLDKSRKGELL |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49840 | Y351 | Sugiyama | GSK3A | EIIKVLGTPTREQIREMNPNyTEFKFPQIKAHPWTKVFKSR |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y288 | Sugiyama | GSK3B | EIIKVLGTPTREQIREMNPNyTEFKFPQIKAHPWTKVFRPR |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50990 | Y426 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | KRLVPGGGAtEIELAKQItsyGETCPGLEQyAIKKFAEAFE |
| P50991 | Y269 | Sugiyama | CCT4 CCTD SRB | IQFCLSAPKTDMDNQIVVSDyAQMDRVLREERAYILNLVKQ |
| P50995 | Y482 | Sugiyama | ANXA11 ANX11 | sEtDLLDIRSEYKRMYGKsLyHDISGDtsGDyRKILLKICG |
| P50995 | Y493 | Sugiyama | ANXA11 ANX11 | YKRMYGKsLyHDISGDtsGDyRKILLKICGGND________ |
| P51149 | Y151 | Sugiyama | RAB7A RAB7 | NRQVATKRAQAWCySKNNIPyFEtSAKEAINVEQAFQtIAR |
| P51531 | Y1439 | Sugiyama | SMARCA2 BAF190B BRM SNF2A SNF2L2 | SGRQLSEVFIQLPSRKELPEyyELIRKPVDFKKIKERIRNH |
| P51532 | Y1497 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | SGRQLSEVFIQLPSRKELPEyyELIRKPVDFKKIKERIRNH |
| P51692 | Y683 | Sugiyama | STAT5B | LNYLIYVFPDRPKDEVySKyytPVPCESATAKAVDGyVKPQ |
| P51784 | Y923 | Sugiyama | USP11 UHX1 | YFDDNSVSPVNENQIESKAAyVLFYQRQDVARRLLsPAGss |
| P51812 | Y707 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | QYQLNRQDAPHLVKGAMAAtysALNRNQsPVLEPVGRsTLA |
| P52272 | Y64 | Sugiyama | HNRNPM HNRPM NAGR1 | AQNEKRKEKNIKRGGNRFEPyANPtKRYRAFITNIPFDVKW |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52298 | Y14 | Sugiyama | NCBP2 CBP20 PIG55 | _______MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQEK |
| P52565 | Y144 | Sugiyama | ARHGDIA GDIA1 | SGMKYIQHTyRKGVKIDKtDyMVGsYGPRAEEyEFLtPVEE |
| P52732 | Y934 | Sugiyama | KIF11 EG5 KNSL1 TRIP5 | EQDLKLDIPtGttPQRKsyLyPSTLVRTEPREHLLDQLKRK |
| P52788 | Y147 | Sugiyama | SMS | ADGRLVEyDIDEVVyDEDsPyQNIKILHSKQFGNILILSGD |
| P52788 | Y336 | Sugiyama | SMS | GNCVNLTEALSLYEEQLGRLyCPVEFSKEIVCVPSYLELWV |
| P53396 | Y659 | Sugiyama | ACLY | TGGMLDNILASKLyRPGsVAyVSRsGGMsNELNNIISRTTD |
| P53611 | Y26 | Sugiyama | RABGGTB GGTB | KDVIIKsDAPDTLLLEKHADyIASYGSKKDDYEYCMSEYLR |
| P53621 | Y391 | Sugiyama | COPA | NPAENAVLLCTRAsNLENstyDLytIPKDADsQNPDAPEGK |
| P54105 | Y214 | Sugiyama | CLNS1A CLCI ICLN | QsVssQYNMAGVRtEDsIRDyEDGMEVDttPtVAGQFEDAD |
| P54577 | S386 | Sugiyama | YARS1 YARS | sRLDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGL |
| P54577 | Y289 | Sugiyama | YARS1 YARS | FPLKSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDL |
| P54577 | Y292 | Sugiyama | YARS1 YARS | KSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDLKNS |
| P54578 | Y436 | Sugiyama | USP14 TGT | GYYDLQAVLTHQGRSssSGHyVSWVKRKQDEWIKFDDDKVs |
| P54646 | Y179 | Sugiyama | PRKAA2 AMPK AMPK2 | GLSNMMsDGEFLRtsCGsPNyAAPEVISGRLYAGPEVDIWS |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P54762 | Y594 | Sugiyama | EPHB1 ELK EPHT2 HEK6 NET | VYSDKLQHYSTGRGsPGMKIyIDPFtyEDPNEAVREFAKEI |
| P54762 | Y600 | Sugiyama | EPHB1 ELK EPHT2 HEK6 NET | QHYSTGRGsPGMKIyIDPFtyEDPNEAVREFAKEIDVSFVK |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55209 | Y106 | Sugiyama | NAP1L1 NRP | VKCAQIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYE |
| P55209 | Y110 | Sugiyama | NAP1L1 NRP | QIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYEPTEE |
| P55263 | Y129 | Sugiyama | ADK | IDKFGEILKRKAAEAHVDAHyyEQNEQPTGTCAACITGDNR |
| P55769 | Y11 | Sugiyama | SNU13 NHP2L1 | __________MTEADVNPKAyPLADAHLTKKLLDLVQQsCN |
| P55795 | Y180 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | AsQEIAEKALKKHKERIGHRyIEIFKSSRAEVRTHYDPPRK |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P55795 | Y82 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EsEEEVKLALKKDRETMGHRyVEVFKSNsVEMDWVLKHtGP |
| P55809 | Y43 | Sugiyama | OXCT1 OXCT SCOT | TWYKGCVCSFSTSAHRHTKFyTDPVEAVKDIPDGATVLVGG |
| P57053 | Y38 | Sugiyama | H2BC12L H2BFS H2BS1 | AVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P57053 | Y43 | Sugiyama | H2BC12L H2BFS H2BS1 | QKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P58876 | Y38 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P58876 | Y43 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P60174 | Y68 | Sugiyama | TPI1 TPI | yIDFARQKLDPKIAVAAQNCyKVTNGAFtGEIsPGMIKDCG |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y294 | Sugiyama | ACTB | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P60709 | Y306 | Sugiyama | ACTB | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P60900 | Y160 | Sugiyama | PSMA6 PROS27 | LIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFLE |
| P60981 | Y82 | Sugiyama | DSTN ACTDP DSN | VTITDPFKHFVGMLPEKDCRyALyDAsFETKESRKEELMFF |
| P61081 | T176 | Sugiyama | UBE2M UBC12 | NRRLFEQNVQRSMRGGyIGstyFERCLK_____________ |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61081 | Y177 | Sugiyama | UBE2M UBC12 | RRLFEQNVQRSMRGGyIGstyFERCLK______________ |
| P61158 | S232 | Sugiyama | ACTR3 ARP3 | EVGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSKW |
| P61158 | Y16 | Sugiyama | ACTR3 ARP3 | _____MAGRLPACVVDCGtGytKLGYAGNTEPQFIIPSCIA |
| P61158 | Y231 | Sugiyama | ACTR3 ARP3 | REVGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSK |
| P61158 | Y233 | Sugiyama | ACTR3 ARP3 | VGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSKWI |
| P61158 | Y400 | Sugiyama | ACTR3 ARP3 | GGSMLASTPEFYQVCHTKKDyEEIGPsICRHNPVFGVMs__ |
| P61163 | Y38 | Sugiyama | ACTR1A CTRN1 | SGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALEGDIFI |
| P61353 | Y75 | Sugiyama | RPL27 | AAMGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtV |
| P61353 | Y77 | Sugiyama | RPL27 | MGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVN |
| P61586 | Y156 | Sugiyama | RHOA ARH12 ARHA RHO12 | QEPVKPEEGRDMANRIGAFGyMECsAKTKDGVREVFEMAtR |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | S215 | Sugiyama | YWHAG | HLAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNLtLWts |
| P61981 | Y216 | Sugiyama | YWHAG | LAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNLtLWtsD |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y214 | Sugiyama | YWHAE | LAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | S69 | Sugiyama | RPS14 PRO2640 | GKETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELG |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62263 | Y72 | Sugiyama | RPS14 PRO2640 | TICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGITA |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | Y18 | Sugiyama | RPS13 | ___MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVKEQIy |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62714 | Y80 | Sugiyama | PPP2CB | GQFHDLMELFRIGGKsPDtNyLFMGDyVDRGYYSVETVTLL |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62750 | Y74 | Sugiyama | RPL23A | LRRQPKYPRKSAPRRNKLDHyAIIKFPLTTEsAMKKIEDNN |
| P62753 | Y156 | Sugiyama | RPS6 OK/SW-cl.2 | KRASRIRKLFNLsKEDDVRQyVVRKPLNKEGKKPRTKAPKI |
| P62807 | Y38 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | AVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssK |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62807 | Y43 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | QKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62873 | Y145 | Sugiyama | GNB1 | NLKTREGNVRVSRELAGHTGyLsCCRFLDDNQIVTSSGDTT |
| P62913 | Y170 | Sugiyama | RPL11 | CIGAKHRISKEEAMRWFQQKyDGIILPGK____________ |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | Y79 | Sugiyama | PPIA CYPA | GFMCQGGDFtRHNGTGGKsIyGEKFEDENFILKHtGPGILs |
| P63092 | Y190 | Sugiyama | GNAS GNAS1 GSP | QLIDCAQYFLDKIDVIKQADyVPSDQDLLRCRVLTSGIFET |
| P63104 | Y211 | Sugiyama | YWHAZ | LAKtAFDEAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63173 | T44 | Sugiyama | RPL38 | KIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPGL |
| P63173 | Y41 | Sugiyama | RPL38 | KSVKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLP |
| P63173 | Y43 | Sugiyama | RPL38 | VKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPG |
| P63220 | T52 | Sugiyama | RPS21 | IQMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRL |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y294 | Sugiyama | ACTG1 ACTG | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P63261 | Y306 | Sugiyama | ACTG1 ACTG | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67775 | Y80 | Sugiyama | PPP2CA | GQFHDLMELFRIGGKsPDtNyLFMGDyVDRGYYSVETVTLL |
| P67809 | Y196 | Sugiyama | YBX1 NSEP1 YB1 | sAPEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGE |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | Y254 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | CILPPtRPTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKP |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68104 | Y85 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | AERERGITIDISLWKFEtsKyyVtIIDAPGHRDFIKNMITG |
| P68104 | Y86 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | ERERGITIDISLWKFEtsKyyVtIIDAPGHRDFIKNMITGT |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | T225 | Sugiyama | TUBA1B | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| P68363 | Y312 | Sugiyama | TUBA1B | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68363 | Y451 | Sugiyama | TUBA1B | DyEEVGVDsVEGEGEEEGEEy____________________ |
| P68366 | T225 | Sugiyama | TUBA4A TUBA1 | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| P68366 | Y312 | Sugiyama | TUBA4A TUBA1 | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| P68400 | Y12 | Sugiyama | CSNK2A1 CK2A1 | _________MSGPVPSRARVytDVNTHRPREYWDYESHVVE |
| P68400 | Y323 | Sugiyama | CSNK2A1 CK2A1 | KLLRYDHQSRLTAREAMEHPyFytVVKDQARMGSSSMPGGS |
| P68400 | Y325 | Sugiyama | CSNK2A1 CK2A1 | LRYDHQSRLTAREAMEHPyFytVVKDQARMGSSSMPGGStP |
| P78345 | Y29 | Sugiyama | RPP38 | GRGsLRKTRPLVVKTSLNNPyIIRWSALESEDMHFILQTLE |
| P78527 | Y4077 | Sugiyama | PRKDC HYRC HYRC1 | AVITCDELLLGHEKAPAFRDyVAVARGSKDHNIRAQEPESG |
| P78527 | Y527 | Sugiyama | PRKDC HYRC HYRC1 | DHRAsGEVRtGKWKVPTYKDyVDLFRHLLSSDQMMDSILAD |
| P78536 | Y433 | Sugiyama | ADAM17 CSVP TACE | AEHDPDGLAECAPNEDQGGKyVMYPIAVSGDHENNKMFSNC |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| P98175 | Y694 | Sugiyama | RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122 | QPISSLRDDERREsAtADAGyAILEKKGALAERQHTsMDLP |
| Q00059 | Y165 | Sugiyama | TFAM TCF6 TCF6L2 | KKKELTLLGKPKRPRsAYNVyVAERFQEAKGDsPQEKLKTV |
| Q00169 | Y140 | Sugiyama | PITPNA PITPN | GTQENVHKLEPEAWKHVEAVyIDIADRSQVLSKDYKAEEDP |
| Q00341 | Y437 | Sugiyama | HDLBP HBP VGL | VNVAQEQIEGMVKDLINRMDyVEINIDHKFHRHLIGKSGAN |
| Q00610 | Y883 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EARIHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsR |
| Q00610 | Y899 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | LAKIyIDsNNNPERFLRENPyyDsRVVGKYCEKRDPHLACV |
| Q00610 | Y900 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AKIyIDsNNNPERFLRENPyyDsRVVGKYCEKRDPHLACVA |
| Q00653 | Y285 | Sugiyama | NFKB2 LYT10 | DDENGWQAFGDFsPTDVHKQyAIVFRTPPYHKMKIERPVTV |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01085 | Y12 | Sugiyama | TIAL1 | _________MMEDDGQPRTLyVGNLSRDVTEVLILQLFSQI |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q01130 | Y44 | Sugiyama | SRSF2 SFRS2 | RtsPDtLRRVFEKYGRVGDVyIPRDRYTKESRGFAFVRFHD |
| Q02809 | Y434 | Sugiyama | PLOD1 LLH PLOD | LWSNFWGALSADGYYARSEDyVDIVQGRRVGVWNVPYISNI |
| Q02878 | T118 | Sugiyama | RPL6 TXREB1 | GDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQHVR |
| Q02878 | Y115 | Sugiyama | RPL6 TXREB1 | PVGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQ |
| Q02878 | Y116 | Sugiyama | RPL6 TXREB1 | VGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQH |
| Q04917 | S215 | Sugiyama | YWHAH YWHA1 | LLAKQAFDDAIAELDtLNEDsyKDstLIMQLLRDNLtLWTS |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05209 | Y88 | Sugiyama | PTPN12 | LPFDHSRVKLTLKtPsQDSDyINANFIKGVYGPKAYVATQG |
| Q05639 | Y254 | Sugiyama | EEF1A2 EEF1AL STN | TILPPTRPTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRP |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q05655 | Y630 | Sugiyama | PRKCD PKCD | LLEKRRLEPPFRPKVKsPRDysNFDQEFLNEKARLsysDKN |
| Q06323 | Y32 | Sugiyama | PSME1 IFI5111 | AKVDVFREDLCTKtENLLGsyFPKKIsELDAFLKEPALNEA |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q06830 | Y34 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | NFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTFVCPT |
| Q07157 | Y1066 | Sugiyama | TJP1 ZO1 | VEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDRVPM |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q07955 | Y189 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | TYAVRKLDNTKFRsHEGEtAyIRVKVDGPRsPsyGRsRsRs |
| Q07960 | Y64 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | sDDsKsssPELVtHLKWDDPyyDIARHQIVEVAGDDKYGRK |
| Q07960 | Y65 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | DDsKsssPELVtHLKWDDPyyDIARHQIVEVAGDDKYGRKI |
| Q08043 | Y229 | Sugiyama | ACTN3 | KLRKDDPIGNLNTAFEVAEKyLDIPKMLDAEDIVNtPKPDE |
| Q08211 | Y68 | Sugiyama | DHX9 DDX9 LKP NDH2 | MGNSTNKKDAQSNAARDFVNyLVRINEIKsEEVPAFGVAsP |
| Q08380 | Y446 | Sugiyama | LGALS3BP M2BP | RKSQLVYQSRRGPLVKYssDyFQAPSDYRYYPYQSFQTPQH |
| Q08J23 | Y51 | Sugiyama | NSUN2 SAKI TRM4 | EAGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALR |
| Q08J23 | Y52 | Sugiyama | NSUN2 SAKI TRM4 | AGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALRE |
| Q12874 | Y50 | Sugiyama | SF3A3 SAP61 | KSTLRDQINSDHRTRAMQDRyMEVSGNLRDLyDDKDGLRKE |
| Q12906 | Y579 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | VEVDGQKFQGAGSNKKVAKAyAALAALEKLFPDtPLALDAN |
| Q12931 | Y498 | Sugiyama | TRAP1 HSP75 HSPC5 | GQLtsLsEyASRMRAGtRNIyyLCAPNRHLAEHsPyyEAMK |
| Q12931 | Y513 | Sugiyama | TRAP1 HSP75 HSPC5 | GtRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDE |
| Q12996 | Y708 | Sugiyama | CSTF3 | NEDsDEDEEKGAVVPPVHDIyRARQQKRIR___________ |
| Q13098 | Y172 | Sugiyama | GPS1 COPS1 CSN1 | YKGNSIKESIRRGHDDLGDHyLDCGDLSNALKCYSRARDYC |
| Q13107 | Y916 | Sugiyama | USP4 UNP UNPH | YFDDSNVSLASEDQIVTKAAyVLFYQRRDDEFYKTPSLSSS |
| Q13131 | Y190 | Sugiyama | PRKAA1 AMPK1 | GLsNMMsDGEFLRtsCGsPNyAAPEVISGRLYAGPEVDIWS |
| Q13162 | Y188 | Sugiyama | PRDX4 | GLGPIRIPLLSDLTHQISKDyGVyLEDSGHTLRGLFIIDDK |
| Q13228 | Y28 | Sugiyama | SELENBP1 SBP | CGPGySTPLEAMKGPREEIVyLPCIyRNtGtEAPDyLATVD |
| Q13228 | Y56 | Sugiyama | SELENBP1 SBP | tGtEAPDyLATVDVDPKsPQyCQVIHRLPMPNLKDELHHSG |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y242 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ESCDTLTCRDCQLNAHKDHQyQFLEDAVRNQRKLLAsLVKR |
| Q13263 | Y517 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQPGtA |
| Q13283 | T21 | Sugiyama | G3BP1 G3BP | MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNssyV |
| Q13283 | Y20 | Sugiyama | G3BP1 G3BP | _MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNssy |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13310 | Y54 | Sugiyama | PABPC4 APP1 PABP4 | AGPVLsIRVCRDMITRRsLGyAyVNFQQPADAERALDtMNF |
| Q13332 | Y1422 | Sugiyama | PTPRS | PGQQFTWEHSNLEVNKPKNRyANVIAYDHSRVILQPIEGIM |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13442 | Y17 | Sugiyama | PDAP1 HASPP28 | ____MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREE |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13596 | Y162 | Sugiyama | SNX1 | QFDLTVGITDPEKIGDGMNAyVAyKVTTQTsLPLFRSKQFA |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q14152 | Y697 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LEKEKKELQERLKNQEKKIDyFERAKRLEEIPLIKSAYEEQ |
| Q14160 | Y1360 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | PPtPGPAAsPEQLsFRERQKyFELEVRVPQAEGPPKRVsLV |
| Q14204 | Y2881 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | IDREKAMSRPILYSNWLSKDyIPVDQEELRDyVKARLKVFY |
| Q14247 | Y545 | Sugiyama | CTTN EMS1 | IDDGWWRGVCKGRyGLFPANyVELRQ_______________ |
| Q14257 | Y122 | Sugiyama | RCN2 ERC55 | AKQQFVEYDKNSDDTVTWDEyNIQMyDRVIDFDENtALDDA |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y39 | Sugiyama | RCN2 ERC55 | AAGAGKAEELHyPLGERRsDyDREALLGVQEDVDEyVKLGH |
| Q14257 | Y54 | Sugiyama | RCN2 ERC55 | ERRsDyDREALLGVQEDVDEyVKLGHEEQQKRLQAIIKKID |
| Q14566 | Y810 | Sugiyama | MCM6 | LTQAGLKGstEGsEsYEEDPyLVVNPNyLLED_________ |
| Q14566 | Y817 | Sugiyama | MCM6 | GstEGsEsYEEDPyLVVNPNyLLED________________ |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14651 | Y463 | Sugiyama | PLS1 | VNKPPYPALGGNMKKIENCNyAVELGKNKAKFSLVGIAGQD |
| Q14677 | Y159 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | AQDDDRLREERKKAKKNKDKyVGVssDsVGGFRysERYDPE |
| Q14677 | Y21 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | MLNMWKVRELVDKATNVVMNySEIESKVREATNDDPWGPSG |
| Q14696 | Y58 | Sugiyama | MESD KIAA0081 MESDC2 MESDM UNQ1911/PRO4369 | PGTPDESTPPPRKKKKDIRDyNDADMARLLEQWEKDDDIEE |
| Q14697 | Y147 | Sugiyama | GANAB G2AN KIAA0088 | RLSVSGRDENSVELTMAEGPyKIILTARPFRLDLLEDRSLL |
| Q14697 | Y60 | Sugiyama | GANAB G2AN KIAA0088 | tCEEssFCKRQRsIRPGLsPyRALLDSLQLGPDSLTVHLIH |
| Q14974 | Y529 | Sugiyama | KPNB1 NTF97 | KLLETTDRPDGHQNNLRSSAyEsLMEIVKNSAKDCYPAVQK |
| Q15024 | Y13 | Sugiyama | EXOSC7 KIAA0116 RRP42 | ________MASVTLSEAEKVyIVHGVQEDLRVDGRGCEDYR |
| Q15024 | Y187 | Sugiyama | EXOSC7 KIAA0116 RRP42 | RVRVLEDEEGsKDIELSDDPyDCIRLSVENVPCIVTLCKIG |
| Q15029 | Y161 | Sugiyama | EFTUD2 KIAA0031 SNRP116 | GKTCFVDCLIEQTHPEIRKRyDQDLCyTDILFTEQERGVGI |
| Q15056 | Y86 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | sIRsVRLVRDKDTDKFKGFCyVEFDEVDsLKEALtyDGALL |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15287 | Y205 | Sugiyama | RNPS1 LDC2 | GKIKMIDMPVERMHPHLSKGyAyVEFENPDEAEKALKHMDG |
| Q15293 | Y140 | Sugiyama | RCN1 RCN | VAKVWKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssD |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15393 | Y1166 | Sugiyama | SF3B3 KIAA0017 SAP130 | MHLRSEHPPLCGRDHLSFRSyyFPVKNVIDGDLCEQFNsME |
| Q15393 | Y1167 | Sugiyama | SF3B3 KIAA0017 SAP130 | HLRSEHPPLCGRDHLSFRSyyFPVKNVIDGDLCEQFNsMEP |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15642 | Y595 | Sugiyama | TRIP10 CIP4 STOT STP | GDGWTRVRRKEGGEGyVPtsyLRVTLN______________ |
| Q15785 | Y25 | Sugiyama | TOMM34 URCC3 | FPDsVEELRAAGNESFRNGQyAEASALyGRALRVLQAQGss |
| Q16222 | Y227 | Sugiyama | UAP1 SPAG2 | KIILEEKNKVSMAPDGNGGLyRALAAQNIVEDMEQRGIWSI |
| Q16543 | Y248 | Sugiyama | CDC37 CDC37A | VDPRACFRQFFTKIKtADRQyMEGFNDELEAFKERVRGRAK |
| Q16644 | Y37 | Sugiyama | MAPKAPK3 | VAPGGPGLGGAPGGRREPKKyAVTDDyQLsKQVLGLGVNGK |
| Q16719 | T85 | Sugiyama | KYNU | DENAIYFLGNSLGLQPKMVKtyLEEELDKWAKIAAYGHEVG |
| Q16719 | Y441 | Sugiyama | KYNU | RGVVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsA |
| Q16719 | Y448 | Sugiyama | KYNU | RNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAETKN___ |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q16778 | Y38 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssK |
| Q16778 | Y41 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q16778 | Y43 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q16832 | T470 | Sugiyama | DDR2 NTRKR3 TKT TYRO10 | DSSMFNNNRsssPSEQGsNStyDRIFPLRPDyQEPSRLIRK |
| Q16832 | Y481 | Sugiyama | DDR2 NTRKR3 TKT TYRO10 | sPSEQGsNStyDRIFPLRPDyQEPSRLIRKLPEFAPGEEES |
| Q16832 | Y736 | GPS6|Sugiyama | DDR2 NTRKR3 TKT TYRO10 | CLVGKNYTIKIADFGMSRNLySGDyyRIQGRAVLPIRWMSW |
| Q16832 | Y740 | GPS6|Sugiyama | DDR2 NTRKR3 TKT TYRO10 | KNYTIKIADFGMSRNLySGDyyRIQGRAVLPIRWMSWEsIL |
| Q16832 | Y741 | GPS6|Sugiyama | DDR2 NTRKR3 TKT TYRO10 | NYTIKIADFGMSRNLySGDyyRIQGRAVLPIRWMSWEsILL |
| Q16832 | Y825 | Sugiyama | DDR2 NTRKR3 TKT TYRO10 | FRDQGRQTYLPQPAICPDSVyKLMLSCWRRDTKNRPSFQEI |
| Q16881 | Y163 | Sugiyama | TXNRD1 GRIM12 KDRF | GRLQKLLKMNGPEDLPKsyDyDLIIIGGGSGGLAAAKEAAQ |
| Q1KMD3 | Y214 | Sugiyama | HNRNPUL2 HNRPUL2 | DGERRGVKRQRDEKDEHGRAyyEFREEAYHsRsKsPLPPEE |
| Q4VXU2 | Y291 | Sugiyama | PABPC1L C20orf119 | ERQNELKRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLR |
| Q4VXU2 | Y297 | Sugiyama | PABPC1L C20orf119 | KRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLRKEFSPY |
| Q53H82 | Y121 | Sugiyama | LACTB2 CGI-83 | IKKLPRNPQREEIIGNGEQQyVyLKDGDVIKTEGATLRVLY |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF6 | Y167 | Sugiyama | HSP90AB4P | GEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIGCL |
| Q58FF7 | Y171 | Sugiyama | HSP90AB3P HSP90BC | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5JTH9 | Y1251 | Sugiyama | RRP12 KIAA0690 | AEYKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQG |
| Q5JTH9 | Y1253 | Sugiyama | RRP12 KIAA0690 | YKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQGQF |
| Q5JWF2 | Y833 | Sugiyama | GNAS GNAS1 | QLIDCAQYFLDKIDVIKQADyVPSDQDLLRCRVLTSGIFET |
| Q5QNW6 | Y38 | Sugiyama | H2BC18 HIST2H2BF | AVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q5QNW6 | Y43 | Sugiyama | H2BC18 HIST2H2BF | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q5T035 | Y67 | Sugiyama | FAM120A2P C9orf129 | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPIN |
| Q5T4S7 | Y3856 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | REAATKSSRTsVQPTFTASQyRALsVLGCGHTSSTKCYGCA |
| Q5VTE0 | Y254 | Sugiyama | EEF1A1P5 EEF1AL3 | CILPPtRPTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKP |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q5VTE0 | Y85 | Sugiyama | EEF1A1P5 EEF1AL3 | AERERGITIDISLWKFEtsKyyVtIIDAPGHRDFIKNMITG |
| Q5VTE0 | Y86 | Sugiyama | EEF1A1P5 EEF1AL3 | ERERGITIDISLWKFEtsKyyVtIIDAPGHRDFIKNMITGT |
| Q6DN03 | Y38 | Sugiyama | H2BC20P HIST2H2BC | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCK |
| Q6DN03 | Y41 | Sugiyama | H2BC20P HIST2H2BC | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DN03 | Y43 | Sugiyama | H2BC20P HIST2H2BC | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6DRA6 | Y38 | Sugiyama | H2BC19P HIST2H2BD | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCK |
| Q6DRA6 | Y41 | Sugiyama | H2BC19P HIST2H2BD | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DRA6 | Y43 | Sugiyama | H2BC19P HIST2H2BD | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6P1J9 | Y40 | Sugiyama | CDC73 C1orf28 HRPT2 | VKGDEVIFGEFSWPKNVKTNyVVWGTGKEGQPREYYTLDSI |
| Q6PD62 | Y530 | Sugiyama | CTR9 KIAA0155 SH2BP1 | MCEFHEAEKLYKNILREHPNyVDCYLRLGAMARDKGNFyEA |
| Q6PEY2 | T225 | Sugiyama | TUBA3E | DNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRFD |
| Q6PKG0 | Y777 | Sugiyama | LARP1 KIAA0731 LARP | APEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDSSQT |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6WCQ1 | Y945 | Sugiyama | MPRIP KIAA0864 MRIP RHOIP3 | DELQTALRDKKYASDKYKDIyTELSIAKAKADCDISRLKEQ |
| Q6XE24 | Y104 | Sugiyama | RBMS3 | YGKIVSTKAILDKNTNQCKGyGFVDFDsPAAAQKAVASLKA |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | T225 | Sugiyama | TUBA1A TUBA3 | DNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRFD |
| Q71U36 | Y312 | Sugiyama | TUBA1A TUBA3 | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71U36 | Y451 | Sugiyama | TUBA1A TUBA3 | DyEEVGVDsVEGEGEEEGEEy____________________ |
| Q7KZF4 | Y109 | Sugiyama | SND1 TDRD11 | KLIGKEVCFtIENKtPQGREyGMIyLGKDTNGENIAEsLVA |
| Q7KZF4 | Y329 | Sugiyama | SND1 TDRD11 | EKLRAAERFAKERRLRIWRDyVAPTANLDQKDKQFVAKVMQ |
| Q7KZF4 | Y476 | Sugiyama | SND1 TDRD11 | SKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLHSK |
| Q7KZI7 | Y53 | Sugiyama | MARK2 EMK1 | NMIRGRNsAtsADEQPHIGNyRLLKTIGKGNFAKVKLARHI |
| Q7L014 | T721 | Sugiyama | DDX46 KIAA0801 | EDYVHRAGRTGRAGNKGyAytFITEDQARYAGDIIKALELS |
| Q7L014 | Y718 | Sugiyama | DDX46 KIAA0801 | NHYEDYVHRAGRTGRAGNKGyAytFITEDQARYAGDIIKAL |
| Q7L014 | Y720 | Sugiyama | DDX46 KIAA0801 | YEDYVHRAGRTGRAGNKGyAytFITEDQARYAGDIIKALEL |
| Q86SX6 | Y85 | Sugiyama | GLRX5 C14orf87 | PQCGFSNAVVQILRLHGVRDyAAyNVLDDPELRQGIKDYSN |
| Q86U42 | Y217 | Sugiyama | PABPN1 PAB2 PABP2 | sVNRVTILCDKFSGHPKGFAyIEFSDKEsVRTSLALDEsLF |
| Q86VM9 | Y371 | Sugiyama | ZC3H18 NHN1 | WNSRIPRDVRDTVLEPyADPyYDYEIERFWRGGQyENFRVQ |
| Q86VP6 | Y372 | Sugiyama | CAND1 KIAA0829 TIP120 TIP120A | AAAKCLDAVVSTRHEMLPEFyKTVsPALISRFKEREENVKA |
| Q86VS8 | Y171 | Sugiyama | HOOK3 | MTAIQELMSKEsPVSAGNDAyVDLDRQLKKTTEELNEALSA |
| Q86X29 | Y372 | Sugiyama | LSR ILDR3 LISCH | YPGGYPGDVDRsssAGGQGsyVPLLRDTDssVAsEVRsGyR |
| Q8IV48 | Y66 | Sugiyama | ERI1 3'EXO THEX1 | QETKGSKFITssAsDFsDPVyKEIAITNGCINRMSKEELRA |
| Q8IVD9 | Y196 | Sugiyama | NUDCD3 KIAA1068 | QKNPDSYNGAVRENYTWsQDyTDLEVRVPVPKHVVKGKQVS |
| Q8IWX8 | Y903 | Sugiyama | CHERP DAN26 SCAF6 | YKGVGVALDDPyENyRRNKsysFIARMKARDECK_______ |
| Q8IZ21 | Y647 | Sugiyama | PHACTR4 PRO2963 | LsQRPtVAELLARKILRFNEyVEVTDAQDYDRRADKPWTKL |
| Q8N0Y7 | S137 | Sugiyama | PGAM4 PGAM3 | RsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYESPK |
| Q8N0Y7 | Y119 | Sugiyama | PGAM4 PGAM3 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8N1G4 | Y257 | Sugiyama | LRRC47 KIAA1185 | LRDKRLEKMVSGCQTRSILEyLRVGGRGGGKGKGRAEGSEK |
| Q8N257 | Y38 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | AVTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssK |
| Q8N257 | Y41 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q8N257 | Y43 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | QKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q8N3D4 | Y1362 | Sugiyama | EHBP1L1 | EPPPSPGEEAGLQRFQDtsQyVCAELQALEQEQRQIDGRAA |
| Q8N684 | Y127 | Sugiyama | CPSF7 | VYDVVELKFAENRANGQSKGyAEVVVASENSVHKLLELLPG |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8NEY1 | Y179 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | tPLAPLAPNLGKPSRIPRGPyAEVKPLSKAPEAAVsEDGKs |
| Q8NHW5 | Y13 | Sugiyama | RPLP0P6 | ________MPREDRATWKSNyFLKIIQLLDDyPKCFIVGAD |
| Q8TEW0 | Y1080 | Sugiyama | PARD3 PAR3 PAR3A | QERIQAKTREFRERQARERDyAEIQDFHRTFGCDDELMYGG |
| Q8WU90 | S135 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | KGDKCKFSHDLTLERKCEKRsVyIDARDEELEKDTMDNWDE |
| Q8WUM4 | Y294 | Sugiyama | PDCD6IP AIP1 ALIX KIAA1375 | IARLQHAAELIKTVASRYDEyVNVKDFSDKINRALAAAKKD |
| Q8WVJ2 | Y145 | Sugiyama | NUDCD2 | ERFQKENPGFDFsGAEIsGNytKGGPDFsNLEK________ |
| Q8WX93 | Y1348 | Sugiyama | PALLD KIAA0992 CGI-151 | QWHQQsQstKPKKVRPSASRyAALsDQGLDIKAAFQPEANP |
| Q92522 | Y48 | Sugiyama | H1-10 H1FX | AALsPsKKRKNSKKKNQPGKySQLVVEtIRRLGERNGSSLA |
| Q93052 | Y296 | Sugiyama | LPP | IPPPGLQPEPGYGYAPNQGRyyEGyyAAGPGyGGRNDsDPt |
| Q93052 | Y300 | Sugiyama | LPP | GLQPEPGYGYAPNQGRyyEGyyAAGPGyGGRNDsDPtyGQQ |
| Q93079 | Y38 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q93079 | Y43 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q96BZ9 | Y96 | Sugiyama | TBC1D20 C20orf140 | VNANDPPPISGKNLRQMSKDyQQVLLDVRRSLRRFPPGMPE |
| Q96C19 | Y83 | Sugiyama | EFHD2 SWS1 | ADLNQGIGEPQsPsRRVFNPytEFKEFSRKQIKDMEKMFKQ |
| Q96D46 | S462 | Sugiyama | NMD3 CGI-07 | FLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRISLAE |
| Q96F86 | Y258 | Sugiyama | EDC3 LSM16 YJDC YJEFN2 PP844 | NERPTRYRHDENILESEPIVyRRIIVPHNVSKEFCTDSGLV |
| Q96G03 | Y177 | Sugiyama | PGM2 MSTP006 | CAGIMItAsHNPKQDNGYKVyWDNGAQIIsPHDKGISQAIE |
| Q96HN2 | Y372 | Sugiyama | AHCYL2 KIAA0828 | LCVPAMNVNDSVTKQKFDNLyCCRESILDGLKRTTDMMFGG |
| Q96IU4 | Y147 | Sugiyama | ABHD14B CIB | QLPGFVPVAPICTDKINAANyAsVKTPALIVYGDQDPMGQT |
| Q96KB5 | Y74 | Sugiyama | PBK TOPK | RGLsHsPWAVKKINPICNDHyRsVYQKRLMDEAKILKsLHH |
| Q96PZ0 | S135 | Sugiyama | PUS7 KIAA1897 | GItKFVSSHQGFSGILKERysDFVVHEIGKDGRISHLNDLs |
| Q96PZ0 | Y568 | Sugiyama | PUS7 KIAA1897 | REMLTADNLDIDNMRHKIRDysLsGAyRKIIIRPQNVSWEV |
| Q96PZ0 | Y574 | Sugiyama | PUS7 KIAA1897 | DNLDIDNMRHKIRDysLsGAyRKIIIRPQNVSWEVVAYDDP |
| Q96QK1 | Y507 | Sugiyama | VPS35 MEM3 TCCCTA00141 | EQSLVGRFIHLLRsEDPDQQyLILNTARKHFGAGGNQRIRF |
| Q99459 | Y788 | Sugiyama | CDC5L KIAA0432 PCDC5RP | ECLKEDVQRQQEREKELQHRyADLLLEKETLKSKF______ |
| Q99460 | Y950 | Sugiyama | PSMD1 | AHGPKIEEEEQEPEPPEPFEyIDD_________________ |
| Q99470 | Y187 | Sugiyama | SDF2 | GRPISGQKEVHGMAQPSQNNyWKAMEGIFMKPSELLKAEAH |
| Q99613 | Y881 | Sugiyama | EIF3C EIF3S8 | EKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRR |
| Q99615 | Y50 | Sugiyama | DNAJC7 TPR2 TTC2 | TFKEQGNAYYAKKDYNEAyNyytKAIDMCPKNASYYGNRAA |
| Q99733 | Y55 | Sugiyama | NAP1L4 NAP2 | PRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQLQV |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99832 | Y438 | Sugiyama | CCT7 CCTH NIP7-1 | KYLRDYSRTIPGKQQLLIGAyAKALEIIPRQLCDNAGFDAt |
| Q99877 | Y38 | Sugiyama | H2BC15 H2BFD HIST1H2BN | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99877 | Y43 | Sugiyama | H2BC15 H2BFD HIST1H2BN | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99879 | Y38 | Sugiyama | H2BC14 H2BFE HIST1H2BM | AINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y43 | Sugiyama | H2BC14 H2BFE HIST1H2BM | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99880 | Y38 | Sugiyama | H2BC13 H2BFC HIST1H2BL | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y43 | Sugiyama | H2BC13 H2BFC HIST1H2BL | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q9BPX3 | Y821 | Sugiyama | NCAPG CAPG NYMEL3 | LLVDLTRPSGLNPQAKtsQDyQALTVHDNLAMKICNEILTs |
| Q9BQE3 | T225 | Sugiyama | TUBA1C TUBA6 | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| Q9BQE3 | Y312 | Sugiyama | TUBA1C TUBA6 | TNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BRK5 | Y342 | Sugiyama | SDF4 CAB45 PSEC0034 | MIAVADENQNHHLEPEEVLKysEFFTGSKLVDYARsVHEEF |
| Q9BS40 | Y20 | Sugiyama | LXN | _MEIPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQA |
| Q9BS40 | Y23 | Sugiyama | LXN | IPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQAsME |
| Q9BSJ8 | Y359 | Sugiyama | ESYT1 FAM62A KIAA0747 MBC2 | RGLSSKDKYVKGLIEGKSDPyALVRLGTQTFCSRVIDEELN |
| Q9BSJ8 | Y822 | Sugiyama | ESYT1 FAM62A KIAA0747 MBC2 | IYMERAEDLPLRKGTKHLsPyAtLTVGDssHKTKTISQTSA |
| Q9BT09 | Y54 | Sugiyama | CNPY3 CTG4A ERDA5 PRAT4A TNRC5 HSPC084 UNQ1934/PRO4409 | QAGAEENDWVRLPSKCEVCKyVAVELKSAFEETGKTKEVIG |
| Q9BUQ8 | Y470 | Sugiyama | DDX23 | LVWITTLPKIDRIEESDQGPyAIILAPTRELAQQIEEETIK |
| Q9BV44 | Y256 | Sugiyama | THUMPD3 | EKHCFTSNEAARDFGGAVQDyFKWKADMTNFDVEVLLNIHD |
| Q9BWD1 | Y130 | Sugiyama | ACAT2 ACTL | DSSIVVAGGMENMSKAPHLAyLRTGVKIGEMPLTDSILCDG |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BZX2 | Y203 | Sugiyama | UCK2 UMPK | SQYITFVKPAFEEFCLPTKKyADVIIPRGADNLVAINLIVQ |
| Q9GZT8 | Y175 | Sugiyama | NIF3L1 ALS2CR1 MDS015 My018 | PSKAPNyPTEGNHRVEFNVNytQDLDKVMSAVKGIDGVsVT |
| Q9H173 | Y126 | Sugiyama | SIL1 UNQ545/PRO836 | YEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEMES |
| Q9H1E3 | S144 | Sugiyama | NUCKS1 NUCKS JC7 | PFQEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPER |
| Q9H1E3 | Y146 | Sugiyama | NUCKS1 NUCKS JC7 | QEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKE |
| Q9H201 | Y17 | Sugiyama | EPN3 | ____MTTSALRRQVKNIVHNySEAEIKVREATSNDPWGPPS |
| Q9H2C0 | Y271 | Sugiyama | GAN GAN1 KLHL16 | IPLSQPQQGEAMLANFKPRGysECIVTVGGEERVSRKPTAA |
| Q9H3G5 | Y205 | Sugiyama | CPVL VLP PSEC0124 UNQ197/PRO223 | QFFQIFPEYKNNDFyVTGESyAGKYVPAIAHLIHSLNPVRE |
| Q9H4F8 | Y407 | Sugiyama | SMOC1 | FKRYVKKKAKPKKCARRFtDyCDLNKDKVISLPELKGCLGV |
| Q9H6T3 | Y90 | Sugiyama | RPAP3 | KESSKKTREENTKNRIKsyDyEAWAKLDVDRILDELDKDDs |
| Q9H814 | Y57 | Sugiyama | PHAX RNUXA | GDsAMRAFQNTAtACAPVSHyRAVESVDSSEESFSDSDDDS |
| Q9HA47 | Y205 | Sugiyama | UCK1 URK1 | TQYTTFVKPAFEEFCLPTKKyADVIIPRGVDNMVAINLIVQ |
| Q9HAP6 | S115 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | ELPKTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLK |
| Q9HAP6 | Y118 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | KTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGD |
| Q9HAS0 | Y38 | Sugiyama | C17orf75 | ssEEGGsAEERRLEPPSSSHyCLysYRGSRLAQQRGDsEDG |
| Q9HB71 | Y165 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | VKTDTVLILCRKKVENTRWDyLtQVEKECKEKEKPsYDtEt |
| Q9HC35 | Y226 | Sugiyama | EML4 C2orf2 EMAPL4 | PKVTKTADKHKDVIINQEGEyIKMFMRGRPItMFIPSDVDN |
| Q9HCC0 | Y520 | Sugiyama | MCCC2 MCCB | ADEAALKEPIIKKFEEEGNPyySsARVWDDGIIDPADTRLV |
| Q9NNW5 | Y591 | Sugiyama | WDR6 | GVTSVTCHGGYVYTTGRDGAyYQLFVRDGQLQPVLRQKSCR |
| Q9NP81 | Y52 | Sugiyama | SARS2 SARSM | RSFTTEKRNRNLLYEYAREGysALPQLDIERFCACPEEAAH |
| Q9NQ50 | Y199 | Sugiyama | MRPL40 NLVCF URIM | TPPIPNYQPPEGRYNDITKVyTQVEFKR_____________ |
| Q9NQA5 | Y647 | Sugiyama | TRPV5 ECAC1 | DRWFLRVENHNDQNPLRVLRyVEVFKNsDKEDDQEHPSEKQ |
| Q9NQR4 | Y202 | Sugiyama | NIT2 CUA002 | TTGPAHWELLQRSRAVDNQVyVAtAsPARDDKASYVAWGHS |
| Q9NRX4 | Y113 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | ysMAyGPAQHAISTEKIKAKyPDyEVtWANDGy________ |
| Q9NRX4 | Y116 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | AyGPAQHAISTEKIKAKyPDyEVtWANDGy___________ |
| Q9NT62 | Y203 | Sugiyama | ATG3 APG3 APG3L | KAKTDAGGEDAILQTRTYDLyITYDKYYQTPRLWLFGYDEQ |
| Q9NTK5 | Y375 | Sugiyama | OLA1 GTPBP9 PRO2455 PTD004 | EEGSENAVKAAGKYRQQGRNyIVEDGDIIFFKFNtPQQPKK |
| Q9NUP9 | S115 | Sugiyama | LIN7C MALS3 VELI3 | ELPKTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLK |
| Q9NUP9 | Y118 | Sugiyama | LIN7C MALS3 VELI3 | KTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGD |
| Q9NXW2 | Y111 | Sugiyama | DNAJB12 | TKGYTAEQVAAVKRVKQCKDyyEILGVSRGASDEDLKKAYR |
| Q9NY12 | Y145 | Sugiyama | GAR1 NOLA1 | FSVKLSENMKASSFKKLQKFyIDPyKLLPLQRFLPRPPGEK |
| Q9NY12 | Y149 | Sugiyama | GAR1 NOLA1 | LSENMKASSFKKLQKFyIDPyKLLPLQRFLPRPPGEKGPPR |
| Q9NY65 | T225 | Sugiyama | TUBA8 TUBAL2 | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| Q9NYB9 | T24 | Sugiyama | ABI2 ARGBPIA | LQMLLEEEIPGGRRALFDsytNLERVADyCENNyIQSADKQ |
| Q9NZB2 | Y418 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPIN |
| Q9NZB2 | Y9 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | ____________MGVQGFQDyIEKHCPsAVVPVELQKLARG |
| Q9NZD8 | Y10 | Sugiyama | SPG21 ACP33 BM-019 GL010 | ___________MGEIKVSPDyNWFRGTVPLKKIIVDDDDSK |
| Q9P032 | Y47 | Sugiyama | NDUFAF4 C6orf66 HRPAP20 HSPC125 My013 | PSVAPRHPsTNSLLREQIsLyPEVKGEIARKDEKLLSFLKD |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UBS4 | Y352 | Sugiyama | DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080 | TEEAREGIKQLLKQGSVQKVyNGLQGY______________ |
| Q9UHX1 | S232 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | QPIIDQLAEEARAFNRIyVAsVHQDLsDDDIKSVFEAFGKI |
| Q9UHX1 | Y269 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | FGKIKSCTLARDPTTGKHKGyGFIEyEKAQSSQDAVSSMNL |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UJU6 | Y16 | Sugiyama | DBNL CMAP SH3P7 PP5423 | _____MAANLSRNGPALQEAyVRVVtEKsPtDWALFTyEGN |
| Q9UJW0 | Y173 | Sugiyama | DCTN4 | QLAQKEKVERDRKKLARRRNyMPLAFSDKYGLGTRLQRPRA |
| Q9UKK9 | Y16 | Sugiyama | NUDT5 NUDIX5 HSPC115 | _____MEsQEPtEssQNGKQyIISEELIsEGKWVKLEKTTY |
| Q9UKN8 | Y353 | Sugiyama | GTF3C4 | VGSAFGPIKILPVNLKAVKGyFTLRQPVILWKEMDQLPVHS |
| Q9ULF5 | Y596 | Sugiyama | SLC39A10 KIAA1265 ZIP10 | RLNEtELtDLEGQQEsPPKNyLCIEEEKIIDHsHsDGLHtI |
| Q9UN86 | Y19 | Sugiyama | G3BP2 KIAA0660 | __MVMEKPsPLLVGREFVRQyytLLNKAPEYLHRFYGRNSS |
| Q9UN86 | Y20 | Sugiyama | G3BP2 KIAA0660 | _MVMEKPsPLLVGREFVRQyytLLNKAPEYLHRFYGRNSSY |
| Q9UNF0 | Y267 | Sugiyama | PACSIN2 | VLLEVQKHLDLSNVAGYKAIyHDLEQsIRAADAVEDLRWFR |
| Q9UNF1 | Y313 | Sugiyama | MAGED2 BCG1 | KDQTKIPIKRSDMLKDIIKEyTDVyPEIIERAGYSLEKVFG |
| Q9UNP9 | Y143 | Sugiyama | PPIE CYP33 | KAETQEGEPIAKKARSNPQVyMDIKIGNKPAGRIQMLLRSD |
| Q9Y230 | Y430 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | SLVCRKRKGtEVQVDDIKRVysLFLDEsRSTQYMKEyQDAF |
| Q9Y265 | Y220 | Sugiyama | RUVBL1 INO80H NMP238 TIP49 TIP49A | VKRQGRCDTYAtEFDLEAEEyVPLPKGDVHKKKEIIQDVtL |
| Q9Y281 | Y82 | Sugiyama | CFL2 | DTVEDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFI |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y3D8 | Y31 | Sugiyama | AK6 CINAP AD-004 CGI-137 | TPGVGKTTLGKELASKSGLKyINVGDLAREEQLYDGYDEEY |
| Q9Y3D8 | Y78 | Sugiyama | AK6 CINAP AD-004 CGI-137 | EDRVVDELDNQMREGGVIVDyHGCDFFPERWFHIVFVLRTD |
| Q9Y3F4 | Y114 | Sugiyama | STRAP MAWD UNRIP | LMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDLNKPEA |
| Q9Y3F4 | Y252 | Sugiyama | STRAP MAWD UNRIP | HPEKEFLVAGGEDFKLyKyDyNsGEELEsyKGHFGPIHCVR |
| Q9Y4E8 | Y926 | Sugiyama | USP15 KIAA0529 | YFDDSSVSTASEDQIVSKAAyVLFYQRQDTFSGTGFFPLDR |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5S9 | Y116 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | yGEIKNIHLNLDRRTGYLKGyTLVEYETyKEAQAAMEGLNG |
| Q9Y5V3 | Y505 | Sugiyama | MAGED1 NRAGE PP2250 PRO2292 | KDYTKVPIKRSEMLRDIIREyTDVyPEIIERACFVLEKKFG |
| Q9Y617 | Y101 | Sugiyama | PSAT1 PSA | GQFSAVPLNLIGLKAGRCADyVVTGAWSAKAAEEAKKFGTI |
| Q9Y617 | Y70 | Sugiyama | PSAT1 PSA | AKIINNTENLVRELLAVPDNyKVIFLQGGGCGQFSAVPLNL |
| Q9Y639 | Y216 | Sugiyama | NPTN SDFR1 SDR1 | KNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKA |
| Q9Y639 | Y220 | Sugiyama | NPTN SDFR1 SDR1 | NMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKAAPDI |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
| Q9Y6G9 | Y101 | Sugiyama | DYNC1LI1 DNCLI1 | TSLIRKIQGIEEYKKGRGLEyLyLNVHDEDRDDQTRCNVWI |
| Q9Y6I3 | Y17 | Sugiyama | EPN1 | ____MSTSSLRRQMKNIVHNySEAEIKVREATSNDPWGPSS |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Recycling pathway of L1 | R-HSA-437239 | 1.026220e-09 | 8.989 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.438764e-09 | 8.842 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.103821e-09 | 8.091 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.087925e-08 | 7.963 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.095794e-08 | 7.960 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.333128e-08 | 7.875 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.927619e-08 | 7.715 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.505920e-08 | 7.259 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 6.588930e-08 | 7.181 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.216484e-08 | 7.085 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.125135e-07 | 6.949 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.523864e-07 | 6.817 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.630201e-07 | 6.580 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.798309e-07 | 6.420 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.448717e-07 | 6.352 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.289880e-07 | 6.277 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.170174e-06 | 5.932 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.939524e-06 | 5.712 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.713186e-06 | 5.567 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.624873e-06 | 5.441 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.126385e-06 | 5.290 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.347275e-06 | 5.078 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 8.405048e-06 | 5.075 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.405048e-06 | 5.075 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.088212e-05 | 4.963 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.416699e-05 | 4.849 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.562771e-05 | 4.806 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.562771e-05 | 4.806 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.703134e-05 | 4.769 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.681828e-05 | 4.774 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.229019e-05 | 4.652 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.397875e-05 | 4.620 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.950141e-05 | 4.530 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.353682e-05 | 4.474 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.353682e-05 | 4.474 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.649962e-05 | 4.438 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.725545e-05 | 4.326 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.902336e-05 | 4.310 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.766771e-05 | 4.239 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.047567e-05 | 4.218 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.926182e-05 | 4.160 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.070740e-05 | 4.093 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.715544e-05 | 4.060 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.115468e-04 | 3.953 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.204404e-04 | 3.919 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.297457e-04 | 3.887 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.314560e-04 | 3.881 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.466655e-04 | 3.834 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 1.471586e-04 | 3.832 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 1.760297e-04 | 3.754 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.782964e-04 | 3.749 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.637660e-04 | 3.786 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.841720e-04 | 3.735 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.979243e-04 | 3.704 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.982283e-04 | 3.703 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.126700e-04 | 3.672 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.108277e-04 | 3.676 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.230866e-04 | 3.652 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.007351e-04 | 3.397 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.593154e-04 | 3.338 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.873470e-04 | 3.312 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.593154e-04 | 3.338 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.490954e-04 | 3.260 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.080888e-04 | 3.150 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.108095e-04 | 3.148 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.282758e-04 | 3.138 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.724500e-04 | 3.059 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.354484e-04 | 3.078 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.088045e-04 | 3.092 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.887088e-04 | 3.103 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.115228e-04 | 3.040 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.179724e-04 | 3.037 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 9.205213e-04 | 3.036 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.812853e-04 | 3.008 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.001517e-03 | 2.999 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.130134e-03 | 2.947 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.368918e-03 | 2.864 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.354148e-03 | 2.868 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.377434e-03 | 2.861 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.383190e-03 | 2.859 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.427590e-03 | 2.845 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.510765e-03 | 2.821 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.510765e-03 | 2.821 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.510765e-03 | 2.821 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.564429e-03 | 2.806 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.578995e-03 | 2.802 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.606654e-03 | 2.794 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.812952e-03 | 2.742 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.927823e-03 | 2.715 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.723776e-03 | 2.764 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.728561e-03 | 2.762 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.115489e-03 | 2.675 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.343110e-03 | 2.630 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.343110e-03 | 2.630 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.439347e-03 | 2.613 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.439347e-03 | 2.613 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.640500e-03 | 2.578 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.789532e-03 | 2.554 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.923105e-03 | 2.534 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.923105e-03 | 2.534 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.923105e-03 | 2.534 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.933810e-03 | 2.533 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.960177e-03 | 2.529 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.221463e-03 | 2.492 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.058062e-03 | 2.392 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 4.058062e-03 | 2.392 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.668470e-03 | 2.436 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.997540e-03 | 2.398 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.460012e-03 | 2.351 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.818104e-03 | 2.317 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 5.373954e-03 | 2.270 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.373954e-03 | 2.270 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.373954e-03 | 2.270 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.578778e-03 | 2.253 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.717069e-03 | 2.243 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.835337e-03 | 2.234 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.835337e-03 | 2.234 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.862967e-03 | 2.232 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.862967e-03 | 2.232 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.995162e-03 | 2.222 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.184277e-03 | 2.209 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.377786e-03 | 2.195 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.009111e-03 | 2.154 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.238814e-03 | 2.140 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.280462e-03 | 2.082 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.405668e-03 | 2.075 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.486163e-03 | 2.126 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.080330e-03 | 2.093 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.070625e-03 | 2.042 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 8.964235e-03 | 2.047 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.584429e-03 | 2.066 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.419614e-03 | 2.026 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 9.647086e-03 | 2.016 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.891722e-03 | 2.005 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 1.061223e-02 | 1.974 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.063200e-02 | 1.973 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.109422e-02 | 1.955 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.110672e-02 | 1.954 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.110672e-02 | 1.954 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.117755e-02 | 1.952 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.117755e-02 | 1.952 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.117755e-02 | 1.952 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.117755e-02 | 1.952 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.117755e-02 | 1.952 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.117755e-02 | 1.952 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.117755e-02 | 1.952 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.117755e-02 | 1.952 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.117755e-02 | 1.952 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.117755e-02 | 1.952 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.117755e-02 | 1.952 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.117755e-02 | 1.952 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.117755e-02 | 1.952 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.117755e-02 | 1.952 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.117755e-02 | 1.952 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.192727e-02 | 1.923 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 1.222108e-02 | 1.913 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.222108e-02 | 1.913 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 1.300910e-02 | 1.886 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.429615e-02 | 1.845 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.783138e-02 | 1.749 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.429615e-02 | 1.845 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.783138e-02 | 1.749 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.429615e-02 | 1.845 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.429615e-02 | 1.845 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 1.560093e-02 | 1.807 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.783138e-02 | 1.749 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.734210e-02 | 1.761 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.623534e-02 | 1.790 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.833807e-02 | 1.737 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.932724e-02 | 1.714 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.972341e-02 | 1.705 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.972341e-02 | 1.705 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.972341e-02 | 1.705 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.034542e-02 | 1.692 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.139264e-02 | 1.670 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.139264e-02 | 1.670 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.246893e-02 | 1.648 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.349622e-02 | 1.629 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.374608e-02 | 1.624 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.470869e-02 | 1.607 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.587213e-02 | 1.587 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.587273e-02 | 1.587 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.697802e-02 | 1.569 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.807367e-02 | 1.552 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.807367e-02 | 1.552 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.807367e-02 | 1.552 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.081543e-02 | 1.511 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.316127e-02 | 1.479 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.316127e-02 | 1.479 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.316127e-02 | 1.479 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.316127e-02 | 1.479 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.428705e-02 | 1.465 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.621878e-02 | 1.441 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.621878e-02 | 1.441 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 3.621878e-02 | 1.441 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.630555e-02 | 1.440 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.758260e-02 | 1.425 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 3.758260e-02 | 1.425 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 4.397016e-02 | 1.357 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.465887e-02 | 1.262 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.012700e-02 | 1.397 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.012700e-02 | 1.397 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.002223e-02 | 1.301 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.204055e-02 | 1.376 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 4.012700e-02 | 1.397 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.813332e-02 | 1.318 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.666423e-02 | 1.247 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.666423e-02 | 1.247 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.337358e-02 | 1.273 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.397016e-02 | 1.357 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.376502e-02 | 1.270 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.511546e-02 | 1.259 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 5.465887e-02 | 1.262 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.012700e-02 | 1.397 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.273473e-02 | 1.369 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.376502e-02 | 1.270 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.666423e-02 | 1.247 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 5.465887e-02 | 1.262 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.361011e-02 | 1.360 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.813332e-02 | 1.318 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.326314e-02 | 1.274 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.540406e-02 | 1.343 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.676146e-02 | 1.330 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.676146e-02 | 1.330 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 5.666423e-02 | 1.247 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.565886e-02 | 1.340 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.092085e-02 | 1.293 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.405522e-02 | 1.356 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.961691e-02 | 1.225 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.961691e-02 | 1.225 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.262152e-02 | 1.203 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 6.404550e-02 | 1.194 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.412990e-02 | 1.193 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 6.522874e-02 | 1.186 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 6.522874e-02 | 1.186 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 6.522874e-02 | 1.186 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 6.522874e-02 | 1.186 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 6.522874e-02 | 1.186 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 6.567655e-02 | 1.183 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.600975e-02 | 1.180 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.660768e-02 | 1.176 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.805781e-02 | 1.167 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.878049e-02 | 1.163 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.193191e-02 | 1.143 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.193191e-02 | 1.143 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.193191e-02 | 1.143 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 7.568106e-02 | 1.121 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 7.568106e-02 | 1.121 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 7.568106e-02 | 1.121 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 7.568106e-02 | 1.121 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 7.568106e-02 | 1.121 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.780831e-02 | 1.109 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.780831e-02 | 1.109 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.837141e-02 | 1.106 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.837141e-02 | 1.106 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.837141e-02 | 1.106 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.193321e-02 | 1.087 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 8.601715e-02 | 1.065 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 8.601715e-02 | 1.065 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 8.601715e-02 | 1.065 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 8.601715e-02 | 1.065 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 8.601715e-02 | 1.065 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 8.601715e-02 | 1.065 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 8.601715e-02 | 1.065 | 0 | 0 |
| M Phase | R-HSA-68886 | 8.643447e-02 | 1.063 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.690808e-02 | 1.061 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 9.623830e-02 | 1.017 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.623830e-02 | 1.017 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 9.623830e-02 | 1.017 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 9.623830e-02 | 1.017 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.063458e-01 | 0.973 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.163408e-01 | 0.934 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.163408e-01 | 0.934 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.163408e-01 | 0.934 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.359986e-01 | 0.866 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.359986e-01 | 0.866 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.456638e-01 | 0.837 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 1.456638e-01 | 0.837 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.552214e-01 | 0.809 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.646727e-01 | 0.783 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.740189e-01 | 0.759 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.180875e-01 | 0.928 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.536958e-01 | 0.813 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.063458e-01 | 0.973 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.454602e-01 | 0.837 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.644331e-01 | 0.784 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.868501e-02 | 1.006 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.644331e-01 | 0.784 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 1.163408e-01 | 0.934 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.835159e-02 | 1.054 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.057533e-01 | 0.976 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.536958e-01 | 0.813 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.428965e-01 | 0.845 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 1.063458e-01 | 0.973 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.057533e-01 | 0.976 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.239820e-01 | 0.907 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.239820e-01 | 0.907 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.239820e-01 | 0.907 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.829366e-02 | 1.054 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.163408e-01 | 0.934 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.359986e-01 | 0.866 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.359986e-01 | 0.866 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.646727e-01 | 0.783 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.646727e-01 | 0.783 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.646727e-01 | 0.783 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.740189e-01 | 0.759 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.254356e-01 | 0.902 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.239820e-01 | 0.907 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.063458e-01 | 0.973 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.262247e-01 | 0.899 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.740189e-01 | 0.759 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.229680e-01 | 0.910 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.039172e-01 | 0.983 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 1.063458e-01 | 0.973 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.262247e-01 | 0.899 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.359986e-01 | 0.866 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.456638e-01 | 0.837 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.552214e-01 | 0.809 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.093376e-01 | 0.961 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.021523e-01 | 0.991 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.021523e-01 | 0.991 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.021523e-01 | 0.991 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.506251e-01 | 0.822 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 1.740189e-01 | 0.759 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 9.623830e-02 | 1.017 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.063458e-01 | 0.973 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.359986e-01 | 0.866 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 1.390650e-01 | 0.857 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.829366e-02 | 1.054 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.022020e-01 | 0.991 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 9.623830e-02 | 1.017 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.262247e-01 | 0.899 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.663192e-01 | 0.779 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.072375e-02 | 1.042 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.682752e-01 | 0.774 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.520343e-02 | 1.021 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.740189e-01 | 0.759 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.584352e-01 | 0.800 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.113225e-01 | 0.953 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.262247e-01 | 0.899 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.223177e-01 | 0.913 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.039051e-01 | 0.983 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.163408e-01 | 0.934 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.212510e-01 | 0.916 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 1.702868e-01 | 0.769 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.157863e-01 | 0.936 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.624162e-02 | 1.017 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.239820e-01 | 0.907 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.523397e-01 | 0.817 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 1.740189e-01 | 0.759 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.166006e-01 | 0.933 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.868501e-02 | 1.006 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.753870e-01 | 0.756 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.781571e-01 | 0.749 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.809394e-01 | 0.742 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.809394e-01 | 0.742 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.832610e-01 | 0.737 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.832610e-01 | 0.737 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.832610e-01 | 0.737 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.832610e-01 | 0.737 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 1.832610e-01 | 0.737 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 1.832610e-01 | 0.737 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.863073e-01 | 0.730 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.903459e-01 | 0.720 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.903459e-01 | 0.720 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.903459e-01 | 0.720 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 1.924003e-01 | 0.716 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.924003e-01 | 0.716 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.924003e-01 | 0.716 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.924003e-01 | 0.716 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 1.924003e-01 | 0.716 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.924003e-01 | 0.716 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.924003e-01 | 0.716 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.930289e-01 | 0.714 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.931999e-01 | 0.714 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.008492e-01 | 0.697 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 2.014379e-01 | 0.696 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 2.014379e-01 | 0.696 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.014379e-01 | 0.696 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.014379e-01 | 0.696 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.025295e-01 | 0.694 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.103749e-01 | 0.677 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.189051e-01 | 0.660 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.192124e-01 | 0.659 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.192124e-01 | 0.659 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.192124e-01 | 0.659 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.192124e-01 | 0.659 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.192124e-01 | 0.659 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 2.192124e-01 | 0.659 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 2.230176e-01 | 0.652 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.247877e-01 | 0.648 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.271363e-01 | 0.644 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.279516e-01 | 0.642 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.279516e-01 | 0.642 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.279516e-01 | 0.642 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.279516e-01 | 0.642 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.279516e-01 | 0.642 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.279516e-01 | 0.642 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.312604e-01 | 0.636 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.334576e-01 | 0.632 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.365935e-01 | 0.626 | 0 | 0 |
| Transport of nucleotide sugars | R-HSA-727802 | 2.365935e-01 | 0.626 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 2.365935e-01 | 0.626 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.395227e-01 | 0.621 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.395227e-01 | 0.621 | 1 | 1 |
| UCH proteinases | R-HSA-5689603 | 2.436595e-01 | 0.613 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.451392e-01 | 0.611 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.451392e-01 | 0.611 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.451392e-01 | 0.611 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.451392e-01 | 0.611 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.451392e-01 | 0.611 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.451392e-01 | 0.611 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.451392e-01 | 0.611 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.451392e-01 | 0.611 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.476395e-01 | 0.606 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.476395e-01 | 0.606 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.516272e-01 | 0.599 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.516272e-01 | 0.599 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.519417e-01 | 0.599 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.535897e-01 | 0.596 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.535897e-01 | 0.596 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.535897e-01 | 0.596 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.535897e-01 | 0.596 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.535897e-01 | 0.596 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.619462e-01 | 0.582 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.619462e-01 | 0.582 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 2.619462e-01 | 0.582 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.619462e-01 | 0.582 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.619462e-01 | 0.582 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 2.619462e-01 | 0.582 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 2.643776e-01 | 0.578 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.702096e-01 | 0.568 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.702096e-01 | 0.568 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 2.726704e-01 | 0.564 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.768158e-01 | 0.558 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 2.783810e-01 | 0.555 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.783810e-01 | 0.555 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 2.783810e-01 | 0.555 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.926135e-01 | 0.534 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.944518e-01 | 0.531 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.944518e-01 | 0.531 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.944518e-01 | 0.531 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.944518e-01 | 0.531 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.944518e-01 | 0.531 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.944518e-01 | 0.531 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 2.944518e-01 | 0.531 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.975143e-01 | 0.526 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.990718e-01 | 0.524 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.023532e-01 | 0.519 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 3.023532e-01 | 0.519 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.023532e-01 | 0.519 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.057715e-01 | 0.515 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 3.074396e-01 | 0.512 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.098937e-01 | 0.509 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.101667e-01 | 0.508 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.101667e-01 | 0.508 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 3.101667e-01 | 0.508 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.140109e-01 | 0.503 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.178931e-01 | 0.498 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.178931e-01 | 0.498 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.181229e-01 | 0.497 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 3.181229e-01 | 0.497 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.220637e-01 | 0.492 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.222292e-01 | 0.492 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.235236e-01 | 0.490 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.255334e-01 | 0.487 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.255334e-01 | 0.487 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.255334e-01 | 0.487 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.276474e-01 | 0.485 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.296424e-01 | 0.482 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.304232e-01 | 0.481 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.330886e-01 | 0.477 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.330886e-01 | 0.477 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.345102e-01 | 0.476 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.345102e-01 | 0.476 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.385900e-01 | 0.470 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.404909e-01 | 0.468 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.405597e-01 | 0.468 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 3.405597e-01 | 0.468 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.426623e-01 | 0.465 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.479475e-01 | 0.458 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.490465e-01 | 0.457 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.552530e-01 | 0.449 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.552530e-01 | 0.449 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.552530e-01 | 0.449 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.552530e-01 | 0.449 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.552530e-01 | 0.449 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.552530e-01 | 0.449 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.552530e-01 | 0.449 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.571450e-01 | 0.447 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.588696e-01 | 0.445 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.624770e-01 | 0.441 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 3.624770e-01 | 0.441 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.628993e-01 | 0.440 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.662858e-01 | 0.436 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.662858e-01 | 0.436 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.669196e-01 | 0.435 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.696206e-01 | 0.432 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.696206e-01 | 0.432 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 3.696206e-01 | 0.432 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 3.696206e-01 | 0.432 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.709302e-01 | 0.431 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.709302e-01 | 0.431 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.766846e-01 | 0.424 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 3.766846e-01 | 0.424 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.766846e-01 | 0.424 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.829008e-01 | 0.417 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.836699e-01 | 0.416 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.836699e-01 | 0.416 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.868697e-01 | 0.412 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.905773e-01 | 0.408 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.908275e-01 | 0.408 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.974077e-01 | 0.401 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.987089e-01 | 0.399 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.003028e-01 | 0.398 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.108410e-01 | 0.386 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.108410e-01 | 0.386 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.115884e-01 | 0.386 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.174455e-01 | 0.379 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.304345e-01 | 0.366 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 4.304345e-01 | 0.366 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.312278e-01 | 0.365 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.353586e-01 | 0.361 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.368205e-01 | 0.360 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.368205e-01 | 0.360 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.431354e-01 | 0.353 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.487122e-01 | 0.348 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.493798e-01 | 0.347 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.493798e-01 | 0.347 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.493798e-01 | 0.347 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.555546e-01 | 0.341 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.555546e-01 | 0.341 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.555546e-01 | 0.341 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.555546e-01 | 0.341 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.555546e-01 | 0.341 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.558656e-01 | 0.341 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.599223e-01 | 0.337 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.676984e-01 | 0.330 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.676984e-01 | 0.330 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.795727e-01 | 0.319 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 4.795727e-01 | 0.319 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.854107e-01 | 0.314 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 4.854107e-01 | 0.314 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.874452e-01 | 0.312 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.911836e-01 | 0.309 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.968921e-01 | 0.304 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.968921e-01 | 0.304 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.015088e-01 | 0.300 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.025369e-01 | 0.299 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 5.081187e-01 | 0.294 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.136382e-01 | 0.289 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.136382e-01 | 0.289 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.136382e-01 | 0.289 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.136382e-01 | 0.289 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.139188e-01 | 0.289 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.190961e-01 | 0.285 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 5.208476e-01 | 0.283 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.244931e-01 | 0.280 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.244931e-01 | 0.280 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.290370e-01 | 0.277 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.351070e-01 | 0.272 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.351070e-01 | 0.272 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.351070e-01 | 0.272 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.351070e-01 | 0.272 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.351070e-01 | 0.272 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.351070e-01 | 0.272 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.351070e-01 | 0.272 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 5.351070e-01 | 0.272 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 5.351070e-01 | 0.272 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 5.351070e-01 | 0.272 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.378807e-01 | 0.269 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.398120e-01 | 0.268 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.403253e-01 | 0.267 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 5.403253e-01 | 0.267 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.454853e-01 | 0.263 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.454853e-01 | 0.263 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 5.505877e-01 | 0.259 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 5.544951e-01 | 0.256 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.556332e-01 | 0.255 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 5.578331e-01 | 0.253 | 1 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.606223e-01 | 0.251 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.609356e-01 | 0.251 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.642606e-01 | 0.249 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 5.704340e-01 | 0.244 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.752578e-01 | 0.240 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.775578e-01 | 0.238 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.801950e-01 | 0.236 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.847445e-01 | 0.233 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 5.847445e-01 | 0.233 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.894085e-01 | 0.230 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.894085e-01 | 0.230 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 5.894085e-01 | 0.230 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 5.894085e-01 | 0.230 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.895500e-01 | 0.229 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.895500e-01 | 0.229 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.940204e-01 | 0.226 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.940204e-01 | 0.226 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.985808e-01 | 0.223 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.985808e-01 | 0.223 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.989354e-01 | 0.223 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.030902e-01 | 0.220 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.030902e-01 | 0.220 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 6.030902e-01 | 0.220 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.075493e-01 | 0.216 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 6.077958e-01 | 0.216 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.119585e-01 | 0.213 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.163185e-01 | 0.210 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.183098e-01 | 0.209 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.206298e-01 | 0.207 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.206298e-01 | 0.207 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.332766e-01 | 0.198 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.340058e-01 | 0.198 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.424348e-01 | 0.192 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.455040e-01 | 0.190 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.455040e-01 | 0.190 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.494891e-01 | 0.187 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 6.507112e-01 | 0.187 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.534296e-01 | 0.185 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.534361e-01 | 0.185 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 6.560407e-01 | 0.183 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 6.573260e-01 | 0.182 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.617546e-01 | 0.179 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.678364e-01 | 0.175 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.687558e-01 | 0.175 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.724808e-01 | 0.172 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.761642e-01 | 0.170 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.834078e-01 | 0.165 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.848318e-01 | 0.164 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.873407e-01 | 0.163 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.954989e-01 | 0.158 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 6.974152e-01 | 0.157 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 7.008197e-01 | 0.154 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 7.108061e-01 | 0.148 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.108061e-01 | 0.148 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.108061e-01 | 0.148 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.138729e-01 | 0.146 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.140607e-01 | 0.146 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.172789e-01 | 0.144 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.204610e-01 | 0.142 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.204610e-01 | 0.142 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 7.230452e-01 | 0.141 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.267188e-01 | 0.139 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.328373e-01 | 0.135 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.363402e-01 | 0.133 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.388195e-01 | 0.131 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.417605e-01 | 0.130 | 0 | 0 |
| Translation | R-HSA-72766 | 7.470248e-01 | 0.127 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 7.475440e-01 | 0.126 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.475440e-01 | 0.126 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.475440e-01 | 0.126 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.531987e-01 | 0.123 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.531987e-01 | 0.123 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.559786e-01 | 0.121 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.587274e-01 | 0.120 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.667903e-01 | 0.115 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.667903e-01 | 0.115 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.720162e-01 | 0.112 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 7.720162e-01 | 0.112 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.720162e-01 | 0.112 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.771255e-01 | 0.110 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.796374e-01 | 0.108 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.805395e-01 | 0.108 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.821210e-01 | 0.107 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.835432e-01 | 0.106 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.870052e-01 | 0.104 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.894062e-01 | 0.103 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.987443e-01 | 0.098 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 8.068475e-01 | 0.093 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.071083e-01 | 0.093 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 8.119849e-01 | 0.090 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.141058e-01 | 0.089 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.283007e-01 | 0.082 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.467290e-01 | 0.072 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 8.501714e-01 | 0.070 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.535369e-01 | 0.069 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 8.535369e-01 | 0.069 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.551914e-01 | 0.068 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 8.568273e-01 | 0.067 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.616255e-01 | 0.065 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.709075e-01 | 0.060 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.819860e-01 | 0.055 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.091672e-01 | 0.041 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.094625e-01 | 0.041 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.126112e-01 | 0.040 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.149677e-01 | 0.039 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.313071e-01 | 0.031 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.324657e-01 | 0.030 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.347383e-01 | 0.029 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.390577e-01 | 0.027 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.468620e-01 | 0.024 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.546706e-01 | 0.020 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.600723e-01 | 0.018 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.714796e-01 | 0.013 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.716960e-01 | 0.012 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.796977e-01 | 0.009 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.799295e-01 | 0.009 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.834834e-01 | 0.007 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.867328e-01 | 0.006 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.907180e-01 | 0.004 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.914381e-01 | 0.004 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.944348e-01 | 0.002 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.961071e-01 | 0.002 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.980114e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.989107e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.995522e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999766e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110223e-16 | 15.955 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.442491e-15 | 14.612 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.769963e-15 | 14.010 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.769963e-15 | 14.010 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.643130e-14 | 13.784 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 8.426593e-14 | 13.074 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.849277e-14 | 13.105 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.815171e-14 | 13.055 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.527312e-14 | 13.123 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.441380e-13 | 12.612 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.441380e-13 | 12.612 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.310996e-13 | 12.365 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 4.575229e-13 | 12.340 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.716538e-13 | 12.243 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.874812e-13 | 12.104 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.153478e-13 | 12.089 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.098233e-12 | 11.959 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.447398e-12 | 11.839 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.452727e-12 | 11.838 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.624034e-12 | 11.789 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.624034e-12 | 11.789 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.022160e-12 | 11.694 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.460809e-12 | 11.609 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.460809e-12 | 11.609 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.234080e-12 | 11.490 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.075851e-12 | 11.390 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.178968e-12 | 11.286 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.198064e-12 | 11.284 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.198064e-12 | 11.284 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.380896e-12 | 11.195 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.591727e-12 | 11.181 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.598566e-12 | 11.066 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.598566e-12 | 11.066 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.772316e-12 | 11.057 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.043132e-11 | 10.982 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.043132e-11 | 10.982 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.025247e-11 | 10.989 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.242051e-11 | 10.906 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.302314e-11 | 10.885 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.302314e-11 | 10.885 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.547806e-11 | 10.810 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.108436e-11 | 10.676 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.001388e-11 | 10.699 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.001388e-11 | 10.699 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.464529e-11 | 10.608 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.690592e-11 | 10.433 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.690592e-11 | 10.433 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.489442e-11 | 10.348 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 7.652445e-11 | 10.116 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 7.652445e-11 | 10.116 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.829759e-11 | 10.007 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.133015e-10 | 9.946 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.133015e-10 | 9.946 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.241481e-10 | 9.906 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.393455e-10 | 9.856 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.349981e-10 | 9.870 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.607965e-10 | 9.794 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.851933e-10 | 9.732 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.899214e-10 | 9.721 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.199428e-10 | 9.495 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.161889e-10 | 9.381 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.247103e-10 | 9.372 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.322194e-10 | 9.274 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.378847e-10 | 9.269 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.679624e-10 | 9.175 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 6.679624e-10 | 9.175 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.657756e-10 | 9.116 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.737100e-10 | 9.111 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.737100e-10 | 9.111 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.946343e-10 | 9.002 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.184209e-09 | 8.927 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.359424e-09 | 8.867 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.377479e-09 | 8.861 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.397543e-09 | 8.855 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.430253e-09 | 8.845 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.220387e-09 | 8.654 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.987446e-09 | 8.525 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.078429e-09 | 8.512 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.616056e-09 | 8.442 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.755818e-09 | 8.425 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.325399e-09 | 8.199 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.693330e-09 | 8.174 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.801947e-09 | 8.108 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 7.801947e-09 | 8.108 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.737424e-09 | 8.059 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.735116e-09 | 8.012 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.091410e-08 | 7.962 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.153505e-08 | 7.938 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.502052e-08 | 7.823 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.127483e-08 | 7.672 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.285245e-08 | 7.641 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.290671e-08 | 7.640 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.536438e-08 | 7.596 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.964667e-08 | 7.528 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.274995e-08 | 7.485 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.399153e-08 | 7.469 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.652714e-08 | 7.437 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.728885e-08 | 7.325 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.754487e-08 | 7.323 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 4.799879e-08 | 7.319 | 1 | 1 |
| Mitotic Prophase | R-HSA-68875 | 5.354559e-08 | 7.271 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.455619e-08 | 7.263 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.530617e-08 | 7.257 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 8.552034e-08 | 7.068 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.359059e-08 | 7.029 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.108306e-07 | 6.955 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.108306e-07 | 6.955 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.312003e-07 | 6.882 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.334309e-07 | 6.875 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.495527e-07 | 6.825 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.679921e-07 | 6.775 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.819171e-07 | 6.740 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.993549e-07 | 6.700 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.231145e-07 | 6.651 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.367521e-07 | 6.626 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.456583e-07 | 6.610 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.460015e-07 | 6.609 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.498941e-07 | 6.602 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.677582e-07 | 6.572 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.933987e-07 | 6.405 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.893420e-07 | 6.310 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.790240e-07 | 6.237 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.022549e-07 | 6.299 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.435696e-07 | 6.265 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 6.696157e-07 | 6.174 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.956440e-07 | 6.158 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.956440e-07 | 6.158 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.956440e-07 | 6.158 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.980886e-07 | 6.156 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.414756e-07 | 6.130 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.902911e-07 | 6.102 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 9.640600e-07 | 6.016 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.287442e-06 | 5.641 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.517840e-06 | 5.599 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.713186e-06 | 5.567 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.901359e-06 | 5.537 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.609136e-06 | 5.443 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.567863e-06 | 5.340 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.656224e-06 | 5.332 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.686678e-06 | 5.329 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.686678e-06 | 5.329 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.205834e-06 | 5.284 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.580894e-06 | 5.253 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 5.967261e-06 | 5.224 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.017252e-06 | 5.221 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.385233e-06 | 5.132 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.397376e-06 | 5.131 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.246068e-06 | 5.084 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.405048e-06 | 5.075 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.114947e-06 | 5.040 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.622463e-06 | 5.017 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.062531e-05 | 4.974 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.100410e-05 | 4.958 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.163506e-05 | 4.934 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.494843e-05 | 4.825 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.496396e-05 | 4.825 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.562771e-05 | 4.806 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.691285e-05 | 4.772 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.703134e-05 | 4.769 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.794894e-05 | 4.746 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.884669e-05 | 4.725 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.242617e-05 | 4.649 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.397875e-05 | 4.620 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.466257e-05 | 4.608 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.616975e-05 | 4.582 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.691860e-05 | 4.570 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.005119e-05 | 4.522 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.441490e-05 | 4.463 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.845678e-05 | 4.415 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.951034e-05 | 4.403 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.066806e-05 | 4.391 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.073802e-05 | 4.390 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.267286e-05 | 4.370 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.967788e-05 | 4.304 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.583519e-05 | 4.339 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.096773e-05 | 4.149 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.188272e-05 | 4.143 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.416648e-05 | 4.130 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.957406e-05 | 4.048 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.980578e-05 | 4.047 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.129630e-04 | 3.947 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.297457e-04 | 3.887 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.371124e-04 | 3.863 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.471586e-04 | 3.832 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.582515e-04 | 3.801 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.637660e-04 | 3.786 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.643326e-04 | 3.784 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.706442e-04 | 3.768 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.709148e-04 | 3.767 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.709148e-04 | 3.767 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.782964e-04 | 3.749 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.982283e-04 | 3.703 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.131175e-04 | 3.671 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.562510e-04 | 3.591 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.562510e-04 | 3.591 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.013036e-04 | 3.521 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.219484e-04 | 3.492 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.529771e-04 | 3.452 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.982003e-04 | 3.400 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.982003e-04 | 3.400 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.982003e-04 | 3.400 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.982003e-04 | 3.400 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.102353e-04 | 3.387 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.325523e-04 | 3.364 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 4.593154e-04 | 3.338 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.299135e-04 | 3.276 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.653130e-04 | 3.177 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.669361e-04 | 3.176 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.961628e-04 | 3.157 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.051295e-04 | 3.152 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.080888e-04 | 3.150 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.108095e-04 | 3.148 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.299360e-04 | 3.081 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.299360e-04 | 3.081 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 9.711380e-04 | 3.013 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 9.938856e-04 | 3.003 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.814552e-04 | 3.055 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.111877e-03 | 2.954 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.110292e-03 | 2.955 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.130134e-03 | 2.947 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.130134e-03 | 2.947 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.133420e-03 | 2.946 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 1.170143e-03 | 2.932 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.364948e-03 | 2.865 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.364948e-03 | 2.865 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.515881e-03 | 2.819 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.641988e-03 | 2.785 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.723776e-03 | 2.764 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.761270e-03 | 2.754 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.889183e-03 | 2.724 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.132382e-03 | 2.671 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 2.151009e-03 | 2.667 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.236062e-03 | 2.651 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.236062e-03 | 2.651 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.246377e-03 | 2.649 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 2.250180e-03 | 2.648 | 1 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.418494e-03 | 2.616 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.541636e-03 | 2.595 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.599471e-03 | 2.585 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.599471e-03 | 2.585 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.640500e-03 | 2.578 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.960177e-03 | 2.529 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.988897e-03 | 2.524 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.152972e-03 | 2.501 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.297946e-03 | 2.482 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.668470e-03 | 2.436 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.883752e-03 | 2.411 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 4.058062e-03 | 2.392 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.058062e-03 | 2.392 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.460012e-03 | 2.351 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.471893e-03 | 2.350 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.542684e-03 | 2.343 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.944565e-03 | 2.306 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.179199e-03 | 2.286 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.373954e-03 | 2.270 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.746351e-03 | 2.241 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.835337e-03 | 2.234 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.835337e-03 | 2.234 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.370865e-03 | 2.196 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.377786e-03 | 2.195 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.563976e-03 | 2.183 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.932222e-03 | 2.159 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.009111e-03 | 2.154 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.117755e-02 | 1.952 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.117755e-02 | 1.952 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.117755e-02 | 1.952 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.117755e-02 | 1.952 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.117755e-02 | 1.952 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.117755e-02 | 1.952 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.117755e-02 | 1.952 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.117755e-02 | 1.952 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.117755e-02 | 1.952 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.117755e-02 | 1.952 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.117755e-02 | 1.952 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.117755e-02 | 1.952 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.117755e-02 | 1.952 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.117755e-02 | 1.952 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.117755e-02 | 1.952 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.280462e-03 | 2.082 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.072969e-02 | 1.969 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.486163e-03 | 2.126 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.110672e-02 | 1.954 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.809883e-03 | 2.008 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.296548e-03 | 2.081 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.002597e-02 | 1.999 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 9.647086e-03 | 2.016 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.729380e-03 | 2.059 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 8.280462e-03 | 2.082 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 9.647086e-03 | 2.016 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 9.647086e-03 | 2.016 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 8.280462e-03 | 2.082 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.573568e-03 | 2.121 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.573568e-03 | 2.121 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.701521e-03 | 2.060 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.141026e-02 | 1.943 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.146133e-02 | 1.941 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 1.146133e-02 | 1.941 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.237216e-02 | 1.908 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.361799e-02 | 1.866 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.361799e-02 | 1.866 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.429615e-02 | 1.845 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.429615e-02 | 1.845 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 1.467054e-02 | 1.834 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.539849e-02 | 1.813 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.554419e-02 | 1.808 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 1.602160e-02 | 1.795 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.602160e-02 | 1.795 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.734680e-02 | 1.761 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.890347e-02 | 1.723 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.999079e-02 | 1.699 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.169564e-02 | 1.664 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.374608e-02 | 1.624 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.374608e-02 | 1.624 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.374608e-02 | 1.624 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.461273e-02 | 1.609 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.470869e-02 | 1.607 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.474746e-02 | 1.606 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.587273e-02 | 1.587 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.587273e-02 | 1.587 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.796531e-02 | 1.553 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.807367e-02 | 1.552 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.034698e-02 | 1.518 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.064993e-02 | 1.514 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.081543e-02 | 1.511 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.212334e-02 | 1.493 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.239280e-02 | 1.490 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.273254e-02 | 1.485 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.316127e-02 | 1.479 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.316127e-02 | 1.479 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.316127e-02 | 1.479 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.316127e-02 | 1.479 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.316127e-02 | 1.479 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.316127e-02 | 1.479 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.428705e-02 | 1.465 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.510327e-02 | 1.455 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.510327e-02 | 1.455 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.510327e-02 | 1.455 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.550075e-02 | 1.450 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.621878e-02 | 1.441 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.630555e-02 | 1.440 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.748750e-02 | 1.426 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.758260e-02 | 1.425 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.758260e-02 | 1.425 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.839076e-02 | 1.416 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.982539e-02 | 1.400 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.012700e-02 | 1.397 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.175740e-02 | 1.379 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.204055e-02 | 1.376 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.207588e-02 | 1.376 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 4.273473e-02 | 1.369 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.273473e-02 | 1.369 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 4.386088e-02 | 1.358 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.397016e-02 | 1.357 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 4.397016e-02 | 1.357 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.397016e-02 | 1.357 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 4.397016e-02 | 1.357 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 4.397016e-02 | 1.357 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 4.397016e-02 | 1.357 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.397016e-02 | 1.357 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.397016e-02 | 1.357 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 4.397016e-02 | 1.357 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.397016e-02 | 1.357 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.397016e-02 | 1.357 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.397016e-02 | 1.357 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.397016e-02 | 1.357 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.397016e-02 | 1.357 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.397016e-02 | 1.357 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.397016e-02 | 1.357 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.397016e-02 | 1.357 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.405522e-02 | 1.356 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.540406e-02 | 1.343 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.540406e-02 | 1.343 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.540406e-02 | 1.343 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.540406e-02 | 1.343 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.832247e-02 | 1.316 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.092085e-02 | 1.293 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.166993e-02 | 1.287 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.465887e-02 | 1.262 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.522874e-02 | 1.186 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 7.568106e-02 | 1.121 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 7.568106e-02 | 1.121 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 8.601715e-02 | 1.065 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.601715e-02 | 1.065 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 8.601715e-02 | 1.065 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 9.623830e-02 | 1.017 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.868501e-02 | 1.006 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.039051e-01 | 0.983 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.837141e-02 | 1.106 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.193191e-02 | 1.143 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.868501e-02 | 1.006 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.868501e-02 | 1.006 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 7.568106e-02 | 1.121 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.868501e-02 | 1.006 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 7.568106e-02 | 1.121 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.601715e-02 | 1.065 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.465887e-02 | 1.262 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 7.568106e-02 | 1.121 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 8.601715e-02 | 1.065 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.376502e-02 | 1.270 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.837141e-02 | 1.106 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.021523e-01 | 0.991 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.021523e-01 | 0.991 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.021523e-01 | 0.991 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.165670e-02 | 1.088 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.600975e-02 | 1.180 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.961691e-02 | 1.225 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.520343e-02 | 1.021 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.193191e-02 | 1.143 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 6.522874e-02 | 1.186 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.522874e-02 | 1.186 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.486055e-02 | 1.261 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.522874e-02 | 1.186 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.582277e-02 | 1.253 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.227541e-02 | 1.206 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.392060e-02 | 1.027 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 8.601715e-02 | 1.065 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.601715e-02 | 1.065 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 9.623830e-02 | 1.017 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.742109e-02 | 1.111 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.020599e-01 | 0.991 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.193191e-02 | 1.143 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.578124e-02 | 1.120 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.600975e-02 | 1.180 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.376502e-02 | 1.270 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.193191e-02 | 1.143 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.511546e-02 | 1.259 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.993437e-02 | 1.155 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.854772e-02 | 1.053 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.175854e-02 | 1.037 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 6.262152e-02 | 1.203 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.252846e-02 | 1.280 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.147108e-02 | 1.211 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.376502e-02 | 1.270 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.498387e-02 | 1.071 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.866468e-02 | 1.006 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.057533e-01 | 0.976 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.063458e-01 | 0.973 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.063458e-01 | 0.973 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.063458e-01 | 0.973 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.063458e-01 | 0.973 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.063458e-01 | 0.973 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 1.063458e-01 | 0.973 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.063458e-01 | 0.973 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.063458e-01 | 0.973 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.068002e-01 | 0.971 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.129537e-01 | 0.947 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.129537e-01 | 0.947 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.156752e-01 | 0.937 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.157863e-01 | 0.936 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.163408e-01 | 0.934 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 1.163408e-01 | 0.934 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.163408e-01 | 0.934 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.163408e-01 | 0.934 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.163408e-01 | 0.934 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.163408e-01 | 0.934 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.163408e-01 | 0.934 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.163408e-01 | 0.934 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 1.163408e-01 | 0.934 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.166006e-01 | 0.933 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.180875e-01 | 0.928 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.180875e-01 | 0.928 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.185310e-01 | 0.926 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.202770e-01 | 0.920 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.226370e-01 | 0.911 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.239820e-01 | 0.907 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.254324e-01 | 0.902 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.254324e-01 | 0.902 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.262247e-01 | 0.899 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 1.262247e-01 | 0.899 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.262247e-01 | 0.899 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.262247e-01 | 0.899 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.262247e-01 | 0.899 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.262247e-01 | 0.899 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.262247e-01 | 0.899 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.279211e-01 | 0.893 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.304242e-01 | 0.885 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.314729e-01 | 0.881 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.320075e-01 | 0.879 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.320766e-01 | 0.879 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.329446e-01 | 0.876 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.329446e-01 | 0.876 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.359701e-01 | 0.867 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.359986e-01 | 0.866 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.359986e-01 | 0.866 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.359986e-01 | 0.866 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.359986e-01 | 0.866 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.359986e-01 | 0.866 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.359986e-01 | 0.866 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.380362e-01 | 0.860 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.406067e-01 | 0.852 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.456638e-01 | 0.837 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 1.456638e-01 | 0.837 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.456638e-01 | 0.837 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.456638e-01 | 0.837 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.456638e-01 | 0.837 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 1.456638e-01 | 0.837 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.456638e-01 | 0.837 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.467501e-01 | 0.833 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.502114e-01 | 0.823 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.506251e-01 | 0.822 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.510474e-01 | 0.821 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.510474e-01 | 0.821 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.510474e-01 | 0.821 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.536958e-01 | 0.813 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.536958e-01 | 0.813 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.545204e-01 | 0.811 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.545204e-01 | 0.811 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.552214e-01 | 0.809 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.552214e-01 | 0.809 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.552214e-01 | 0.809 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.552214e-01 | 0.809 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.623684e-01 | 0.789 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.623684e-01 | 0.789 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.646727e-01 | 0.783 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 1.646727e-01 | 0.783 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 1.646727e-01 | 0.783 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.646727e-01 | 0.783 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.646727e-01 | 0.783 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.646727e-01 | 0.783 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.646727e-01 | 0.783 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.646727e-01 | 0.783 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.646727e-01 | 0.783 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.646727e-01 | 0.783 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.646727e-01 | 0.783 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.649979e-01 | 0.783 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.663192e-01 | 0.779 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.702868e-01 | 0.769 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.721466e-01 | 0.764 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.740189e-01 | 0.759 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.740189e-01 | 0.759 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.740189e-01 | 0.759 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.740189e-01 | 0.759 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.742702e-01 | 0.759 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.742702e-01 | 0.759 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 1.781571e-01 | 0.749 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.781571e-01 | 0.749 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.809394e-01 | 0.742 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.809394e-01 | 0.742 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.822813e-01 | 0.739 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.832610e-01 | 0.737 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.832610e-01 | 0.737 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.832610e-01 | 0.737 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.832610e-01 | 0.737 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.832610e-01 | 0.737 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.832610e-01 | 0.737 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 1.832610e-01 | 0.737 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.832610e-01 | 0.737 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.847378e-01 | 0.733 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 1.924003e-01 | 0.716 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.924003e-01 | 0.716 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.924003e-01 | 0.716 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.924003e-01 | 0.716 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.924003e-01 | 0.716 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.924003e-01 | 0.716 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.924003e-01 | 0.716 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.924003e-01 | 0.716 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.924003e-01 | 0.716 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.924003e-01 | 0.716 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.014379e-01 | 0.696 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.014379e-01 | 0.696 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.014379e-01 | 0.696 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.014379e-01 | 0.696 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.052061e-01 | 0.688 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 2.103749e-01 | 0.677 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.103749e-01 | 0.677 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 2.103749e-01 | 0.677 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 2.103749e-01 | 0.677 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.103749e-01 | 0.677 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 2.103749e-01 | 0.677 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.103749e-01 | 0.677 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.107010e-01 | 0.676 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.107010e-01 | 0.676 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.147993e-01 | 0.668 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.189051e-01 | 0.660 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.192124e-01 | 0.659 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.192124e-01 | 0.659 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.192124e-01 | 0.659 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 2.192124e-01 | 0.659 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.192124e-01 | 0.659 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 2.230176e-01 | 0.652 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 2.230176e-01 | 0.652 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.271363e-01 | 0.644 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.279516e-01 | 0.642 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.279516e-01 | 0.642 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.279516e-01 | 0.642 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.279516e-01 | 0.642 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.279516e-01 | 0.642 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.312604e-01 | 0.636 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.312604e-01 | 0.636 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.312604e-01 | 0.636 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.365935e-01 | 0.626 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.365935e-01 | 0.626 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.365935e-01 | 0.626 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.365935e-01 | 0.626 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.365935e-01 | 0.626 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.365935e-01 | 0.626 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.451392e-01 | 0.611 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.451392e-01 | 0.611 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.451392e-01 | 0.611 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.451392e-01 | 0.611 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.451392e-01 | 0.611 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.451392e-01 | 0.611 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 2.497690e-01 | 0.602 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.519417e-01 | 0.599 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 2.519417e-01 | 0.599 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.535897e-01 | 0.596 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.535897e-01 | 0.596 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.535897e-01 | 0.596 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.535897e-01 | 0.596 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.535897e-01 | 0.596 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.535897e-01 | 0.596 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.536273e-01 | 0.596 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.589571e-01 | 0.587 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.602314e-01 | 0.585 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.619462e-01 | 0.582 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.619462e-01 | 0.582 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.619462e-01 | 0.582 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 2.619462e-01 | 0.582 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.619462e-01 | 0.582 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.619462e-01 | 0.582 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.619462e-01 | 0.582 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.685241e-01 | 0.571 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.686839e-01 | 0.571 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.702096e-01 | 0.568 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.702096e-01 | 0.568 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.702096e-01 | 0.568 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.702096e-01 | 0.568 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.702096e-01 | 0.568 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.783810e-01 | 0.555 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.783810e-01 | 0.555 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.809600e-01 | 0.551 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.851024e-01 | 0.545 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.864614e-01 | 0.543 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.864614e-01 | 0.543 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.864614e-01 | 0.543 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.864614e-01 | 0.543 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.892426e-01 | 0.539 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.933800e-01 | 0.533 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.944518e-01 | 0.531 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.944518e-01 | 0.531 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.944518e-01 | 0.531 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.944518e-01 | 0.531 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.944518e-01 | 0.531 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.944518e-01 | 0.531 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.944518e-01 | 0.531 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.944518e-01 | 0.531 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.944518e-01 | 0.531 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.944518e-01 | 0.531 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.944518e-01 | 0.531 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.023532e-01 | 0.519 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.023532e-01 | 0.519 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.023532e-01 | 0.519 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.023532e-01 | 0.519 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 3.023532e-01 | 0.519 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.024075e-01 | 0.519 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.051781e-01 | 0.515 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.101667e-01 | 0.508 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.101667e-01 | 0.508 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.101667e-01 | 0.508 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.101667e-01 | 0.508 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.101667e-01 | 0.508 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.140109e-01 | 0.503 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.150041e-01 | 0.502 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.174056e-01 | 0.498 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.178931e-01 | 0.498 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.178931e-01 | 0.498 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.178931e-01 | 0.498 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.178931e-01 | 0.498 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.178931e-01 | 0.498 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.178931e-01 | 0.498 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.178931e-01 | 0.498 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.222292e-01 | 0.492 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.235236e-01 | 0.490 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.235236e-01 | 0.490 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.255334e-01 | 0.487 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 3.255334e-01 | 0.487 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.255334e-01 | 0.487 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.255334e-01 | 0.487 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.255334e-01 | 0.487 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.255334e-01 | 0.487 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 3.276474e-01 | 0.485 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.304232e-01 | 0.481 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.330886e-01 | 0.477 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.330886e-01 | 0.477 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.330886e-01 | 0.477 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.330886e-01 | 0.477 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.385900e-01 | 0.470 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.405597e-01 | 0.468 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.405597e-01 | 0.468 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 3.405597e-01 | 0.468 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.405597e-01 | 0.468 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.426623e-01 | 0.465 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 3.479475e-01 | 0.458 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.552530e-01 | 0.449 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.552530e-01 | 0.449 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.552530e-01 | 0.449 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.552530e-01 | 0.449 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.552530e-01 | 0.449 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.624770e-01 | 0.441 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.624770e-01 | 0.441 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.624770e-01 | 0.441 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.628993e-01 | 0.440 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 3.662858e-01 | 0.436 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 3.662858e-01 | 0.436 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 3.696206e-01 | 0.432 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.766846e-01 | 0.424 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 3.766846e-01 | 0.424 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.766846e-01 | 0.424 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 3.803595e-01 | 0.420 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 3.836699e-01 | 0.416 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.836699e-01 | 0.416 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.836699e-01 | 0.416 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.836699e-01 | 0.416 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.836699e-01 | 0.416 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.836699e-01 | 0.416 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.836699e-01 | 0.416 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 3.836699e-01 | 0.416 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.905773e-01 | 0.408 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.905773e-01 | 0.408 | 0 | 0 |
| Translation | R-HSA-72766 | 3.943602e-01 | 0.404 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 3.974077e-01 | 0.401 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.974077e-01 | 0.401 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.987089e-01 | 0.399 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.041620e-01 | 0.393 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.041620e-01 | 0.393 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.041620e-01 | 0.393 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.041620e-01 | 0.393 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.041620e-01 | 0.393 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.065431e-01 | 0.391 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.108410e-01 | 0.386 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.108410e-01 | 0.386 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.108410e-01 | 0.386 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.108410e-01 | 0.386 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.108410e-01 | 0.386 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.108410e-01 | 0.386 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.174455e-01 | 0.379 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.174455e-01 | 0.379 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 4.174455e-01 | 0.379 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.174455e-01 | 0.379 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.174455e-01 | 0.379 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.239764e-01 | 0.373 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.304345e-01 | 0.366 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.304345e-01 | 0.366 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.304345e-01 | 0.366 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.335661e-01 | 0.363 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.368205e-01 | 0.360 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.431354e-01 | 0.353 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.431354e-01 | 0.353 | 0 | 0 |
| Methylation | R-HSA-156581 | 4.431354e-01 | 0.353 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 4.461706e-01 | 0.350 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 4.487122e-01 | 0.348 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.493798e-01 | 0.347 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 4.493798e-01 | 0.347 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.493798e-01 | 0.347 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.555546e-01 | 0.341 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.555546e-01 | 0.341 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.555546e-01 | 0.341 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.555546e-01 | 0.341 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.555546e-01 | 0.341 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.555546e-01 | 0.341 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.558656e-01 | 0.341 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 4.558656e-01 | 0.341 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.676984e-01 | 0.330 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.676984e-01 | 0.330 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.676984e-01 | 0.330 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 4.709998e-01 | 0.327 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.736688e-01 | 0.325 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.736688e-01 | 0.325 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.783095e-01 | 0.320 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.795727e-01 | 0.319 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.854107e-01 | 0.314 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.911836e-01 | 0.309 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.968921e-01 | 0.304 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 4.968921e-01 | 0.304 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 5.136382e-01 | 0.289 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.136382e-01 | 0.289 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.136382e-01 | 0.289 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.139188e-01 | 0.289 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 5.190961e-01 | 0.285 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.190961e-01 | 0.285 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.242874e-01 | 0.280 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.244931e-01 | 0.280 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.244931e-01 | 0.280 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 5.298298e-01 | 0.276 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.298298e-01 | 0.276 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 5.298298e-01 | 0.276 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.351070e-01 | 0.272 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.351070e-01 | 0.272 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.351070e-01 | 0.272 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.351070e-01 | 0.272 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.351070e-01 | 0.272 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.351070e-01 | 0.272 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.403253e-01 | 0.267 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.454853e-01 | 0.263 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.454853e-01 | 0.263 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.454853e-01 | 0.263 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 5.544951e-01 | 0.256 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.556332e-01 | 0.255 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.556332e-01 | 0.255 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.642606e-01 | 0.249 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.642606e-01 | 0.249 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.704340e-01 | 0.244 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.704340e-01 | 0.244 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.706857e-01 | 0.244 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.738726e-01 | 0.241 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.847445e-01 | 0.233 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.847445e-01 | 0.233 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 5.894085e-01 | 0.230 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.895500e-01 | 0.229 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.030902e-01 | 0.220 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.075493e-01 | 0.216 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.119585e-01 | 0.213 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.119585e-01 | 0.213 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.163185e-01 | 0.210 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.206298e-01 | 0.207 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.206298e-01 | 0.207 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.206298e-01 | 0.207 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 6.248928e-01 | 0.204 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.291083e-01 | 0.201 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.291083e-01 | 0.201 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.311620e-01 | 0.200 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 6.332766e-01 | 0.198 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.332766e-01 | 0.198 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.455040e-01 | 0.190 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.494891e-01 | 0.187 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.534296e-01 | 0.185 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.573260e-01 | 0.182 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.573260e-01 | 0.182 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 6.573260e-01 | 0.182 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.724808e-01 | 0.172 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.724808e-01 | 0.172 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.834078e-01 | 0.165 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.869690e-01 | 0.163 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.904903e-01 | 0.161 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.974152e-01 | 0.157 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 7.008197e-01 | 0.154 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.075147e-01 | 0.150 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.267188e-01 | 0.139 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.267188e-01 | 0.139 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.328373e-01 | 0.135 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.358452e-01 | 0.133 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.417605e-01 | 0.130 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.531987e-01 | 0.123 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.667903e-01 | 0.115 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.720162e-01 | 0.112 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 7.735417e-01 | 0.112 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 8.081346e-01 | 0.093 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.098399e-01 | 0.092 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.098399e-01 | 0.092 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.119849e-01 | 0.090 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.361409e-01 | 0.078 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 8.484023e-01 | 0.071 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.647351e-01 | 0.063 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.709075e-01 | 0.060 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.833207e-01 | 0.054 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 8.993648e-01 | 0.046 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.049337e-01 | 0.043 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.091672e-01 | 0.041 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.404334e-01 | 0.027 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.450095e-01 | 0.025 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.468620e-01 | 0.024 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.625852e-01 | 0.017 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.659846e-01 | 0.015 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.854264e-01 | 0.006 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.914381e-01 | 0.004 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.923715e-01 | 0.003 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.943089e-01 | 0.002 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.974312e-01 | 0.001 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.988074e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.998841e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999964e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999997e-01 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
